2021 Georgia Code
Title 16 - Crimes and Offenses
Chapter 13 - Controlled Substances
Article 3 - Dangerous Drugs
§ 16-13-71. "Dangerous Drug" Defined

1. A "dangerous drug" means any drug other than a drug contained in any schedule of Article 2 of this chapter, which, under the federal Food, Drug, and Cosmetic Act (52 Stat. 1040 (1938)), 21 U.S.C. Section 301, et seq., as amended, may be dispensed only upon prescription. In any civil or criminal action or other proceedings, a certification from the Food and Drug Administration of the United States Department of Health and Human Services attesting to the fact that a drug other than a drug contained in any schedule of Article 2 of this chapter involved in the action or proceeding is a dangerous drug that federal law prohibits dispensing of without a prescription pursuant to the federal Food, Drug, and Cosmetic Act shall be admissible as prima-facie proof that such drug is a "dangerous drug."
2. In addition to subsection (a) of this Code section, a "dangerous drug" means any other drug or substance declared by the General Assembly to be a dangerous drug; to include any of the following drugs, chemicals, or substances; salts, isomers, esters, ethers, or derivatives of such drugs, chemicals, or substances which have essentially the same pharmacological action; all other salts, isomers, esters, ethers, and compounds of such drugs, chemicals, or substances unless specifically exempted and the following devices, identified as "dangerous drugs":

   (.03) Abacavir;

   (.031) Abaloparatide;

   (.033) Abametapir;

   (.035) Abarelix;

   (.037) Abatacept;

   (.04) Abciximab;

   (.041) Abemaciclib;

   (.042) Abiraterone;

   (.043) AbobotulinumtoxinA;

   (.044) Acalabrutinib;

   (.045) Acamprostate;

   (.05) Acarbose;

   (.1) Acebutolol;

   1. Acecarbromal;
   2. Acenocoumarol;
   3. Acetazolamide;

      (3.5) Reserved;

   4. Acetohexamide;

      (4.1) Aceto-hydroxamic acid;

   5. Acetophenazine;
   6. Acetosulfone;
   7. Acetyl sulfamethoxypyridazine;
   8. Acetyl sulfisoxazole;
   9. Acetylcarbromal;
   10. Acetylcholine;
   11. Acetylcysteine;
   12. Acetyldigitoxin;

       (12.1) Acitretin;

       (12.5) Aclidinium bromide;

   13. Acrisorcin;

       (13.3) Acrivastine;

       (13.5) Acyclovir;

       (13.53) Adalimumab;

(13.531) Adalimumab-atto;

(13.55) Adapalene - See exceptions;

(13.6) Adenosine;

Adenosine 5-monophosphate;

(14.5) Adenovirus;

Adenylic acid;

Adiphenine hydrochloride;

(16.5) Ado-trastuzumab;

Adrenal cortex extracts;

(17.05) Afamelanotide;

(17.1) Afatinib;

(17.3) Aflibercept;

(17.4) Air polymer-type A;

(17.5) Albendazole;

(17.6) Albiglutide;

(17.7) Albiraterone;

Albumin, normal human serum;

(18.1) Albuterol;

Albutonium;

(19.3) Alcaftadine;

(19.5) Alclometasone dipropionate;

(19.57) Alectinib;

(19.58) Alemtuzumab;

(19.6) Alendronate;

(19.65) Alfuzosin;

(19.7) Alglucerase;

(19.75) Alglucosidase alfa;

(19.76) Alirocumab;

(19.77) Aliskiren;

(19.8) Alitretinoin;

Alkaverir;

Alkavervir;

(21.1) Alkyl nitrites;

Allopurinol;

(22.2) Almotriptan;

(22.3) Alogliptin;

(22.5) Alosetron;

(22.7) Alpelisib;

Alpha amylase;

(23.1) Alprostadil;

Alseroxylon;

(24.1) Altenodol;

(24.6) Altretamine;

Aluminum nicotinate;

Alverine;

(26.5) Alvimopan;

Amantadine;

Ambenonium chloride;

(28.5) Ambrisentan;

Ambrosiacae follens;

Amcinonide;

(30.1) Amdinocillin;

(30.4) Amifampridine;

(30.5) Amifostine;

Amikacin;

(31.1) Amiloride;

Aminacrine;

4-amino-N-methyl-pteroylglutamic acid;

Amino acid preparations for injection or vaginal use;

Aminocaproic acid;

Aminohippurate;

(36.5) Aminolevulinic acid;

Aminophylline;

Aminosalicylate - See exceptions;

Aminosalicylate calcium - See exceptions;

Aminosalicylate potassium - See exceptions;

Aminosalicylate sodium - See exceptions;

Aminosalicylic acid - See exceptions;

(42.1) Amiodarone;

Amisometradine;

(43.5) Amisulpride;

Amitriptyline;

(44.3) Amlexanox;

(44.5) Amlodipine;

(44.6) Ammonia, N-13;

(44.7) Ammonium lactate;

Amodiaquin;

(45.5) Amoxapine;

Amoxicillin;

Amphotericin B;

Ampicillin;

(48.2) Amprenavir;

(48.6) Amrinone;

Amyl nitrite;

Amylolytic enzymes;

(50.1) Anabolic steroids, if listed in Code Section 16-13-27.1 as being exempt as Schedule III controlled substances;

(50.3) Anagrelide;

(50.4) Anakinra;

(50.5) Anastrozole;

Androgens, except those androgens listed in paragraph (6) of Code Section 16-13-27;

(51.5) Angiotensin II;

Angiotensin amide;

(52.5) Anidulafungin;

Anisindione;

Anisotropine;

(54.5) Ansuvimab-zykl;

Antazoline;

Anterior pituitary hormones;

Anthralin;

Anti-coagulant acid:

Citrate dextrose;

Antigens:

Alternaria tenius;

Aqua ivy;

Ash mix;

Aspergillus fumigatus;

Bacterial, Staphylococcus aureus, Type 1;

Bacterial, Staphylococcus aureus, Type 3;

Bacterial, Undenatured;

Bee;

Beech;

Bermuda grass;

Birch;

California live oak;

Candida albicans;

Careless weed;

Cat epithelia;

Cattle epithelia;

Coccidioides immitis;

Cottonwood fremont;

Dog epithelia;

Elm mix;

English plantain;

Feather mix;

Gram negative bacterial;

Helminthosporium sativum;

Hickory;

Hormodendrum hordei;

Hornet;

House dust;

House dust mix;

Insects;

Intradermal or scratching test;

Johnson grass;

Kentucky blue grass;

Kochia;

Lamb quarters;

Maple;

Mesquite;

Mixed epidermals;

Mixed grass, ragweeds (spring-fall);

Mixed grasses (spring);

Mixed inhalants;

Mixed molds;

Mixed ragweed;

Mixed ragweed - mixed weeds (fall);

Mixed weeds;

Molds;

Mountain cedar;

Mugwort common;

National weed mix;

Oak mix;

Olive;

Orchard grass;

Pecan;

Penicillium notatum;

Perennial rye;

Poison oak and poison ivy;

Pollens;

Poplar mix;

Prescription;

Ragweed mix;

Red top grass;

Respiratory bacterial;

Rough pigweed;

Russian thistle;

Sagebrush common;

Scale mix;

Short ragweed;

Simplified allergy screening set;

Skin bacterial;

Southern grass;

Staphylococcal;

Stinging insect mix;

Stinging insects;

Sweet vernal;

Sycamore;

Tall ragweed;

Timothy;

Tree mix;

Trees (early spring);

Walnut;

Wasp;

West ragweed;

West weed mix;

Yellow jacket;

Antihemophilic factor, Human;

Antirabies serum;

Antivenin;

(62.03) Apalutamide;

(62.05) Apixaban;

(62.1) Apomorphine;

(62.3) Apraclonidine;

(62.38) Apremilast;

(62.4) Aprepitant;

(62.5) Aprotinin;

(62.7) Ardeparin;

(62.75) Arformoterol tartrate;

(62.8) Argatroban;

Arginine, L-;

(63.5) Aripiprazole;

Arsenic - Preparation for human use;

(64.1) Arsenic trioxide;

Artegraft;

(65.5) Artemether;

(65.7) Artesunate;

Ascorbate sodium - Injection;

(66.5) Asenapine;

(66.7) Asfotase;

Asparaginase;

(67.6) Astemizole;

(67.67) Astenajavol;

(67.72) Atazanavir;

(68.1) Atenolol;

(68.13) Atezolizumab;

(68.14) Atoltivimab;

(68.15) Atomoxetine;

(68.2) Atorvastatin;

(68.3) Atovaquone;

(68.4) Atracurium besylate;

(68.5) Atropine - See exceptions;

(68.6) Auranofin;

Aurothioglucose;

(69.1) Avanafil;

(69.10) Avatrombopag;

(69.105) Avapritinib;

(69.11) Avelumab;

(69.2) Avibactam;

(69.3) Axitinib;

(69.5) Azacitidine;

Azapetine;

Azatadine maleate;

Azathioprine;

(72.3) Azelaic acid;

(72.4) Azelastine;

(72.43) Azficel-T;

(72.45) Azilsartan;

(72.5) Azithromycin;

(72.7) Azlocillin;

Azo-sulfisoxazole;

(73.5) Aztreonam;

Azuresin;

Bacitracin - See exceptions;

Baclofen;

(76.3) Baloxavir marboxil;

(76.5) Balsalazide;

(76.8) Baricitinib;

Barium - See exceptions;

(77.3) Bazedoxifene;

(77.5) Beclomethasone;

Bedaquiline;

(78.2) Belantamab mafodotin-blmf;

(78.3) Belatacept;

(78.5) Belimumab;

(78.7) Belinostat;

Belladonna;

Belladonna alkaloids;

Belladonna extracts;

(81.5) Bempedoic acid;

Benactyzine;

(82.5) Benazepril;

(82.7) Bendamustine;

Bendroflumethiazide;

(83.1) Benoxaprofen;

(83.11) Benralizumab;

(83.2) Bentiromide;

(83.5) Bentoquatam - See exceptions;

Benzestrol;

(84.1) Benznidazole;

Benzonatate;

Benzoylpas;

Benzquinamide;

Benzthiazide;

Benztropine;

Benzylpenicilloyl - polylysine;

Bephenium hydroxynaphthoate;

(91.3) Bepotastine;

(91.5) Bepridil;

(91.7) Beractant;

(91.75) Berotralstat;

(91.8) Besifloxacin;

Beta-carotene - See exceptions;

Betadine vaginal gel;

Betahistine;

(94.5) Betaine, anhydrous;

Betamethasone;

(95.1) Betaxolol;

Betazole;

Bethanechol;

(97.1) Bethanidine sulfate;

(97.11) Betrixaban;

(97.2) Bevacizumab;

(97.3) Bexarotene;

(97.4) Bezlotoxumab;

(97.5) Bicalutamide;

(97.7) Bictegravir sodium;

Bile extract;

(98.2) Bimatoprost;

(98.6) Binimetinib;

Biperiden;

Bisacodyl tannex;

Bishydroxycoumarin;

(101.5) Biskalcitrate;

Bismuth sodium tartrate - See exceptions;

(102.05) Bisoprolol;

(102.1) Bitolterol mesylate;

(102.5) Bivalirudin;

Blastomycine;

Bleomycin;

(104.3) Blinatumomab;

(104.5) Boceprevir;

Boroglycerin glycerite;

(105.3) Bortezomib;

(105.5) Bosentan;

(105.6) Bosutinib;

(105.7) Botulinum toxin (B);

Botulism antitoxin;

(106.3) Bremelanotide;

(106.5) Brentuxima vedotin;

Bretylium;

(107.1) Reserved;

(107.2) Brexpaprazole;

(107.3) Briazolamide;

(107.4) Brigatinib;

(107.45) Brilliant blue G ophthalmic solution;

(107.5) Brimonidine;

(107.6) Brodalumab;

(107.7) Brolucizumab-dbll;

Bromelains - See exceptions;

(108.5) Bromfenac;

Bromisovalum;

Bromocriptine;

Bromodiphenhydramine;

Brompheniramine - See exceptions;

Brucella antigen;

Brucella protein nucleate;

Buclizine;

(115.3) Budesonide - See exceptions;

(115.5) Bumetanide;

Bupivacaine;

(116.1) Bupropion;

(116.3) Burosumab-twza;

(116.5) Buspirone;

Busulfan;

Butacaine;

Butaperazine;

(119.05) Butenafine - See exceptions;

(119.1) Butoconazole - See exceptions;

Reserved;

Butyl nitrite;

Butyrophenone;

(122.3) Cabazitaxel;

(122.5) Cabergoline;

(122.7) Cabozantinib;

Cadmium sulfide - See exceptions;

Caffeine sodium benzoate;

(124.1) Calaspargase pegol-mknl;

(124.3) Calcifediol;

(124.7) Calcipotriene;

Calcitonin, Salmon;

Calcitriol;

Calcium disodium edetate - See exceptions;

Calcium gluconogalactogluconate;

Calcium levulinate;

(129.5) Calfactant;

Calusterone;

(130.1) Canagliflozin;

(130.3) Canakinumab;

(130.5) Candesartan;

Candicidin;

(131.5) Cangrelor;

Cantharidin;

(132.5) Capecitabine;

(132.7) Caplacizumab-yhdp;

(132.9) Capmatinib;

Capreomycin;

(133.05) Capsaicin - See exceptions;

(133.1) Captopril;

Capyodiame;

Caramiphen;

Carbachol;

Carbamazepine;

Carbazochrome;

Carbenicillin;

Carbetapentane;

Carbidopa;

Carbinoxamine;

(142.5) Carboplatin;

(142.7) Carfilzomib;

Carglumic Acid;

(143.5) Cariprazine;

Carmustine;

(144.1) Carnitine;

Carphenazine;

(145.6) Carteolol;

(145.8) Carvedilol;

Casein hydrolysate;

(146.6) Caspofungin;

Catarrhalis combined vaccine;

Catarrhalis vaccine mixed;

(148.5) Cedazuridine;

Cefaclor;

Cefadroxil;

Cefamandole;

(151.3) Cefazolin;

(151.4) Cefdinir;

(151.45) Cefditoren;

(151.5) Cefepime;

(151.55) Cefiderocol;

(151.6) Cefixime;

(151.7) Cefmetazole;

(151.8) Cefonicid;

Cefoperazone;

(152.1) Ceforanide;

(152.2) Cefotaxime;

(152.3) Cefotetan;

(152.7) Cefotiam;

(152.9) Cefoxitin;

(153.1) Cefpiramide;

(153.2) Cefpodoxime;

(153.3) Cefprozil;

(153.35) Ceftaroline;

(153.4) Ceftazidime;

(153.5) Ceftibuten;

(153.6) Ceftizoxime;

(153.7) Ceftolozane;

(153.8) Ceftriaxone;

(153.9) Cefuroxime;

(153.95) Celecoxib;

Cellulose, Oxadized, Regenerated - See exceptions;

(154.3) Cemiplimab-rwlc;

(154.4) Cenegermin-bkbj;

(154.45) Reserved;

(154.5) Centruroides [Scorpion] Immune;

Cephalexin;

Cephaloglycin;

Cephaloridine;

Cephalothin;

Cephapirin;

(159.3) Cephradine;

(159.6) Ceretec;

(159.7) Ceritinib;

(159.8) Cerivastatin;

(159.9) Cerliponase alfa;

Certolizumab;

(160.1) Ceruletide;

(160.15) Cetirizine - See exceptions;

(160.16) Cetrorelix;

(160.165) Cetuximab;

(160.17) Cevimeline;

(160.20) Chenodiol;

Chlophedianol;

Chlorambucil;

Chloramphenicol;

Chloranil - See exceptions;

Chlordantoin;

Chlordiazepoxide in combination with clidinium bromide or water soluble esterified estrogens;

(166.5) Chlorhexidine - See exceptions;

Chlormadinone;

Chlormerodrin;

Chlormezanone;

Chloroacetic acid - See exceptions;

Chlorobutanol - See exceptions;

Chloroform - See exceptions;

Chloroguanide;

Chloroprocaine;

Chloroquine;

Chlorothiazide;

Chlorotrianisene;

Chloroxine;

Chlorphenesin;

Chlorpheniramine - See exceptions;

Chlorphenoxamine;

Chlorpromazine;

Chlorpropamide;

Chlorprothixene;

Chlorquinaldol;

Chlortetracycline;

Chlorthalidone;

Chlorzoxazone;

Cholera vaccine;

Cholestyramine resin;

(190.3) Cholic Acid;

(190.5) Choline C 11;

Chondroitin;

(191.5) Chymopapain;

Chymotrypsin;

(192.02) Ciclesonide;

(192.03) Ciclopirox;

(192.05) Cidofovir;

(192.1) Cilastatin;

(192.4) Cilexetil;

(192.7) Cilostazol;

Cimetidine - See exceptions;

(193.5) Cinacalcet;

Cinoxacin;

(194.5) Ciprofloxacin;

(194.7) Cisapride;

(194.8) Cisatracurium;

Cisplatin;

(195.2) Citalopram;

(195.3) Cladribine;

(195.5) Clarithromycin;

(195.6) Clascoterone;

(195.7) Clavulanate;

Clemastine - See exceptions;

(196.5) Clevidipine;

Clidinium bromide;

Clindamycin;

(198.1) Clobetasol propionate;

Clocortolone pivalate;

Clofibrate;

Clomiphene;

(201.5) Clomipramine;

Clonidine;

Clopidogrel;

Clostridiopeptidase;

Clotrimazole - See exceptions;

Cloxacillin;

(206.5) Clozapine;

Coal tar solution topical;

(207.5) Cobicistat;

(207.7) Cobimetinib;

Cobra venom;

(208.5) Coccidioides immitis;

Colchicine - See exceptions;

(209.5) Colesevelam;

Colestipol;

Colistimethate;

Colistin;

Collagenase;

(213.1) Collagenase clostridium histolyticum;

(213.3) Conivaptan;

(213.4) Copanlisib;

(213.45) Copper dotatate Cu-64;

(213.5) Corticorelin;

Corticotropin;

Corticotropin, Respository;

Cortisone;

Cosyntropin;

(217.4) Crisaborole;

(217.5) Crixivan;

(217.7) Crizanlizumab-tmca;

(217.8) Crizotinib;

(217.9) Crofelemer;

Cromolyn - See exceptions;

Crotaline antivenin, Polyvalent;

Crotamiton;

Cryptenamine;

(221.5) Cupric chloride - injectable;

Cyanide antidote;

Cyclacillin;

Cyclandelate;

Reserved;

Cyclobenzaprine;

Cyclomethycaine;

Cyclopentamine;

Cyclopentolate;

Cyclophosphamide;

Cycloserine;

(231.5) Cyclosporine;

Cyclothiazide;

Cycrimine;

Cyproheptadine;

(234.5) Cysteamine;

Cytarabine;

(235.5) Dabigatran;

(235.7) Dabrafenib;

Dacarbazine;

(236.5) Daclatasvir;

(236.6) Daclizumab;

(236.8) Dacomitinib;

Dactinomycin;

(237.05) Dalbavancin;

(237.1) Dalfampridine;

(237.2) Dalfopristin;

(237.5) Dalteparin;

(237.7) Danaparoid;

Danazol;

Dantrolene;

(239.4) Dapagliflozin;

(239.5) Dapiprazole;

Dapsone - See exceptions;

(240.3) Daptomycin;

(240.4) Daratumumab;

(240.5) Darbepoetin alfa;

(240.6) Darifenacin;

(240.65) Darolutamide;

(240.7) Darunavir;

(240.8) Dasabuvir;

(240.9) Dasatinib;

Daunorubicin;

Deanol;

Decamethonium;

(243.3) Decitabine;

(243.5) Deferasirox;

(243.7) Deferiprone;

Deferoxamine;

(244.2) Defibrotide;

(244.3) Deflazacort;

(244.4) Degarelix;

(244.41) Delafloxacin;

(244.5) Delavirdine;

Demecarium;

Demeclocycline;

Demethylchlortetracycline;

(247.7) Denosumab;

(247.8) Deoxycholic Acid;

Deoxyribonuclease, Pancreatic;

Deserpidine;

(249.5) Desflurane;

Desipramine;

(250.5) Desirudin;

Deslanoside;

(251.5) Desloratadine;

Desmopressin;

(252.5) Desogestrel;

Desonide;

Desoximetasone;

Desoxycorticosterone;

Desoxyribonuclease;

(256.5) Desvenlafaxine;

(256.6) Deutetrabenazine;

Dexamethasone;

Dexbrompheniramine - See exceptions;

Dexchlorpheniramine;

(259.5) Dexlansoprazole;

Dexpanthenol;

(260.5) Dexrazoxane;

Dextran;

Reserved;

Dextriferron;

Dextroisoephedrine;

Dextrothyroxine;

(265.5) Dezocine;

Diatrizoate;

Diazoxide;

Dibucaine;

Dichloralphenazone;

Dichlorphenamide;

(270.5) Diclofenac - See exceptions;

Dicloxacillin;

Dicyclomine;

(272.5) Didanosine;

Dienestrol;

(273.5) Dienogest;

Diethylcarbamazine;

Diethylstilbestrol;

Reserved;

Diflorasone diacetate;

(277.5) Diflunisal;

(277.57) Difluprednate;

Digitalis;

Digitoxin;

Digoxin;

Dihydroergocornine;

Dihydroergocristine;

Dihydroergocryptine;

Dihydroergotamine;

Dihydrostreptomycin;

Dihydrotachysterol;

Diiodohydroxyquin;

(287.5) Diltiazem;

Dimenhydrinate - Injection or suppositories;

Dimercaprol;

Dimethindene;

Dimethisterone;

(291.5) Dimethyl fumarate;

Dimethyl sulfoxide - See exceptions;

Dimethyl tubocurarine;

(293.5) Dimyristoyl;

Dinoprost;

Dinoprostone;

(295.5) Dinutuximab;

Dioxyline;

Diphemanil;

Diphenadione;

Diphenhydramine - See exceptions;

Diphenidol;

Diphenylhydantoin;

Diphenylpyraline;

Diphtheria antitoxin;

Diphtheria and tetanus toxoids;

Diphtheria and tetanus toxoids and pertussis vaccine;

Diphtheria and tetanus toxoids, Absorbed;

Diphtheria and tetanus toxoids, Pertussis;

Diphtheria toxoid;

Dipivefrin;

Dipyridamole;

Dipyron;

(311.3) Dirithromycin;

(311.5) Disibind;

Disodium edetate - See exceptions;

Disopyramide;

Disulfiram;

(314.5) Divalproex;

Dobutamine;

(315.5) Docetaxel;

(315.7) Docosanol - See exceptions;

Doderlein bacilli;

(316.2) Dofetilide;

(316.3) Dolasetron;

(316.4) Dolutegravir;

(316.5) Donepezil;

Dopamine;

(317.1) Doravirine;

(317.2) Doripenem;

(317.3) Dornase Alpha;

(317.4) Dorzolamide;

(317.5) Doxacurium;

Doxapram;

(318.5) Doxazosin mesylate;

Doxepin;

(319.5) Doxercalciferol;

Doxorubicin;

Doxycycline;

Reserved;

Doxylamine;

Dromostanolone;

(324.5) Dronedarone;

Droperidol;

(325.3) Drospirenone;

(325.4) Drotrecogin alfa;

(325.43) Droxidopa;

(325.44) Dulaglutide;

(325.45) Duloxetine;

(325.46) Dupilumab;

(325.47) Durvalumab;

(325.5) Dutasteride;

(325.8) Duvelisib;

Dyclonine;

Dydrogesterone;

Dyphylline;

(328.5) Ecallantide;

Echothiophate;

(329.5) Econazole;

Ectylurea;

(330.3) Eculizumab;

(330.4) Edaravone;

(330.5) Edetate - See exceptions;

(330.7) Edoxaban;

Edrophonium;

(331.03) Efavirenz;

(331.04) Efinaconazole;

(331.05) Eflornithine;

(331.051) Elagolix sodium;

(331.052) Elapegademase-lvlr;

(331.053) Elbasvir;

(331.054) Elexacaftor;

(331.055) Eliglustat;

(331.058) Elosulfase;

(331.059) Elotuzumab;

(331.06) Eltrombopag;

(331.065) Elvitegravir;

(331.068) Emapalumab-lzsg;

(331.07) Emedastine;

(331.0701) Emicizumab;

(331.071) Empagliflozin;

(331.072) Emtricitabine;

(331.1) Enalapril;

(331.6) Enalaprilat;

(331.7) Enasidenib;

(331.9) Encorafenib;

Enflurane;

(332.1) Enfortumab vedotin-ejfv;

(332.2) Enfuvirtide;

(332.5) Enoxacin;

(332.7) Enoxaparin;

(332.8) Entacapone;

(332.85) Entecavir;

(332.86) Entrectinib;

(332.87) Enzalutamide;

(332.88) Epidiolex: A drug product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the United States Food and Drug Administration (FDA) that contains cannabidiol (CBD) derived from cannabis and contains no more than 0.1 percent (w/w) residual tetrahydrocannabinols;

(332.9) Epinastine;

Epinephrine - See exceptions;

Epinephryl borate;

(334.3) Epirubicin;

(334.4) Eplerenone;

(334.5) Epoprostenol;

(334.7) Eprosartan;

(334.8) Eptifibatide;

(334.85) Eptinezumab-jjmr;

(334.9) Eravacycline;

(334.91) Erdafitinib;

(334.92) Erenumab-aooe;

Ergocalciferol - See exceptions;

(335.5) Ergoloid mesylates;

Ergonovine;

Ergotamine;

Ergosine;

Ergocristine;

Ergocryptine;

Ergocornine;

Ergotaminine;

Ergosinine;

Ergocristinine;

Ergocryptinine;

Ergocorninine;

(346.05) Eribulin;

(346.1) Erlotinib;

(346.5) Ertapenem;

(346.7) Ertugliflozin;

Erythrityl tetranitrate;

Erythromycin;

(348.722) Escitalopram;

Eserine;

(349.3) Eslicarbazepine;

(349.4) Esmolol;

(349.7) Esomeprazole - See exceptions;

Esterified estrogens;

Estradiol;

Estriol;

Estrogens;

Estrogenic substances;

Estrone;

(355.5) Estropipate;

(355.6) Etanercept-szzs;

(355.7) Etelcalcetide;

(355.8) Eteplirsen;

Ethacrynate;

Ethacrynic acid;

Ethambutol;

Ethamivan;

(359.5) Ethanolamine oleate;

Ethaverine;

Ether - See exceptions;

(361.5) Reserved;

Ethinyl estradiol;

Ethiodized oil;

Ethionamide;

Ethisterone;

Ethoheptazine;

Ethopropazine;

Ethosuximide;

Ethotoin;

Ethoxazene - See exceptions;

Ethoxyzolamide;

Ethyl biscoumacetate;

Ethyl chloride - See exceptions;

Ethyl nitrite spirit;

Reserved;

Ethylnorepinephrine;

Ethynodiol diacetate;

Etidocaine;

Etidronate;

(379.05) Etodolac;

(379.07) Etomidate;

(379.09) Etonogestrel;

(379.1) Etoposide;

(379.5) Etravirine;

Eucatropine;

(380.3) Everolimus;

(380.4) Evolocumab;

(380.5) Exemestane;

(380.6) Exenatide;

(380.7) Ezetimibe;

Factor IX complex, Human;

(381.1) Famciclovir;

(381.2) Famotidine - See exceptions;

(381.25) Fedratinib;

(381.3) Felbamate;

(381.5) Felodipine;

(381.55) Fenfibrate;

(381.6) Fenofenadine;

(381.7) Fenofibrate;

(381.75) Fenofibric acid;

(381.8) Fenoldopam;

Fenoprofen;

(382.25) Febuxostat;

Ferric cacodylate;

(383.15) Ferric Hexacyanoferrate;

(383.2) Ferric maltol;

(383.3) Ferumoxides;

(383.4) Ferumoxsil;

(383.43) Ferumoxytol;

(383.45) Fesoterodine;

(383.5) Fexofenadine - See exceptions;

Fibrinogen;

Fibrinogen/antihemophilic factor, Human;

Fibrinolysin, Human;

(386.05) Fidaxomicin;

(386.1) Filgrastim-SNDZ;

(386.3) Finasteride;

(386.5) Filgrastin;

(386.6) Finafloxacin;

(386.7) Fingolimod;

(386.9) Fish oil triglycerides;

Flavoxate;

(387.1) Flecainide acetate;

(387.7) Flibanserin;

Florantyrone;

(388.3) Florbetapir F 18;

(388.4) Flortaucipir F 18;

(388.5) Flosequinan;

Floxuridine;

(389.5) Fluconazole;

Flucytosine;

(390.5) Fludarabine;

(390.7) Fludeoxyglucose;

Fludrocortisone;

(391.5) Flumazenil;

Flumethasone;

(392.1) Flunisolide;

Fluocinonide;

Fluocinolone;

Fluorescein;

Fluoride - See exceptions;

(396.3) Fluorodopa F 18;

(396.4) Fluoroestradiol F 18;

(396.5) Fluorometholone;

Fluorophosphates;

Fluorouracil;

Fluoxetine;

(399.5) Fluoxymesterone;

Fluphenazine;

Fluprednisolone;

Flurandrenolide;

(402.2) Flurbiprofen;

(402.5) Flutamide;

(402.6) Flutemetamol F18;

(402.7) Fluticasone - See exceptions;

(402.8) Fluvastatin;

(402.9) Fluvoxamine;

Folate sodium;

Folic acid - See exceptions;

(404.3) Follitropin;

(404.5) Fomivirsen;

(404.7) Fondaparinux;

Foreign protein;

Formaldehyde - See exceptions;

(406.2) Formoterol;

(406.3) Fosamprenavir;

(406.35) Fosaprepitant;

(406.4) Foscarnet;

(406.5) Fosfomycin;

(406.7) Fosinopril;

(406.9) Fosphenytoin;

(406.93) Fostamatinib;

(406.935) Fostemsavir;

(406.94) Fremanezumab-vfrm;

(406.95) Frovatriptan;

Furazolidone;

Furosemide;

(408.1) Ga-68-DOTATOC;

(408.2) Gabapentin;

(408.25) Gadobenate;

(408.27) Gadobutrol;

(408.3) Gadodiamide;

(408.35) Gadofosveset;

(408.4) Gadopentetate dimeglumine;

(408.5) Gadoterate meglumine;

(408.6) Gadoteridol;

(408.8) Gadoversetamide;

(408.85) Gadoxetate;

(408.9) Galantamine;

(408.95) Galcanezumab-gnlm;

Gallamine triethiodide;

(409.1) Gallium 68 PSMA-11;

(409.3) Gallium citrate;

(409.5) Gallium nitrate;

(409.8) Galsulfase;

Gamma benzene hexachloride;

Gamma globulin;

(411.5) Ganciclovir;

(411.7) Ganirelix;

Gas gangrene polyvalent antitoxin;

(412.03) Gatifloxacin;

(412.04) Gefitinib;

(412.05) Gemcitabine;

(412.1) Gemfibrozil;

(412.2) Gemifloxacin;

(412.3) Gemtuzumab ozogamicin;

(412.5) Genotropin;

Gentamicin;

Gentian violet vaginal suppositories;

(414.5) Gilteritinib;

Gitalin;

(415.01) Givosiran;

(415.02) Glasdegib;

(415.03) Glatiramer;

(415.04) Glecaprevir;

(415.05) Glimepiride;

(415.1) Glipizide;

Glucagon;

(416.5) Glucarpidase;

Gluceptate;

Gluconate magnesium;

Gluconate potassium - See exceptions;

Glutamate arginine;

(420.1) Glyburide;

(420.2) Glycerol phenylbutyrate;

(420.5) Glycine - See exceptions;

Glycobiarsol;

Glycopyrrolate;

Gold sodium thiomalate;

Gold thiosulfate - See exceptions;

(424.4) Golimumab;

(424.6) Golodirsen;

Gomenol Solution;

(425.5) Gonadorelin acetate;

Gonadotropin, Chorionic;

Gonadotropin, Chorionic, Anti-human serum;

Gonadotropin, Serum;

(428.5) Goserelin;

Gramicidin;

Gramineae pollens;

(430.3) Gramosetron;

(430.5) Granisetron;

(430.7) Grazoprevir;

Griseofulvin;

(431.5) Guanabenz;

Guanethidine;

(432.4) Guanadrel;

(432.7) Guanfacine;

(432.9) Guanidine;

(432.91) Guselkumab;

Halcinonide;

(433.5) Halobetasol Propionate;

(433.7) Halofantrine;

Haloperidol;

Haloprogin;

Halothane;

Hartman's solution;

Heparin;

Hetacillin;

Hexachlorophene - See exceptions;

Hexafluorenium;

Hexocyclium;

Hexylcaine;

Histamine;

Histoplasmin;

(445.5) Histrelin acetate;

Homatropine;

(446.4) Human secretin;

(446.6) Hyaluronan;

(446.7) Hyaluronic acid;

Hyaluronidase;

Hydralazine;

Hydrocalciferol;

Hydrochlorothiazide;

Hydrocortamate;

Hydrocortisone - See exceptions;

Hydroflumethiazide;

Hydroquinone;

Hydroxocobalamin - See exceptions;

Hydroxyamphetamine;

Hydroxychloroquine;

Hydroxyprogesterone;

Hydroxyurea;

Hydroxyzine;

Hyoscyamine;

Hyoscyamus alkaloids;

Hypophamine;

(463.01) Ibalizumab-uiyk;

(463.03) Ibandronate;

(463.5) Ibrutinib;

Ibuprofen - See exceptions;

(464.05) Ibutilide;

(464.07)Icatibant;

(464.1) Idarubicin;

(464.15) Idarucizumab;

(464.2) Idelalisib;

(464.3) Idoxuridine;

(464.5) Idursulfase;

(464.6) Ifosfamide;

(464.67) Iloperidone;

(464.7) Iloprost;

(464.8) Imatinib;

Imiglucerase;

(465.1) Imipenem/cilastatin;

Imipramine;

(466.5) Imiquimod;

Immune hepatitis B globulin, Human;

Immune poliomyelitis globulin, Human;

Immune serum globulin, Human;

(469.05) IncobotulinumtoxinA;

(469.07) Indacaterol;

(469.1) Indapamide;

(469.5) Indecainide;

Indigotindisulfonate;

(470.05) Indinavir;

(470.1) Indium IN-III oxyquinolone;

(470.3) Indium IN-III pentetreotide;

Indocyanine green;

Indomethacin;

(472.3) Inebilizumab-cdon;

(472.5) Infliximab;

(472.51) Infliximab-dyyb;

Influenza virus vaccines;

(473.5) Ingenol mebutate;

Injections, All substances for human use - See exceptions;

(474.01) Inotersen;

(474.1) Inotuzumab ozogamicin;

(474.2) Insulin aspart;

(474.3) Insulin degludec;

(474.4) Insulin glargine;

(474.45) Insulin glulisine;

(474.5) Interferon;

Intrinsic factor concentrate manufactured for human use;

(475.3) Inulin;

(475.5) Iobenguane;

Iocetamic acid;

Iodamide;

Iodinated I-125 serum albumin;

Iodinated I-131 serum albumin;

Iodinated glycerol-theophylline;

Iodine solution, Strong oral;

Iodipamide;

(482.5) Iodixanol;

Iodized oil;

Iodobenzoic acid - See exceptions;

Iodobrassid;

(485.1) Iodohippurate sodium;

Iodopyracet;

Iodothiouracil;

(487.05) Iofetamine;

(487.06) Ioflupane;

(487.08) Iohexol;

(487.1) Iopamidol;

Iopanoic acid - See exceptions;

Iophendylate;

(489.1) Iopromide;

(489.2) Iothalamate;

(489.3) Iothiouracil;

(489.5) Iotrolan;

(489.6) Ioversol;

(490.1) Ioxaglate;

(490.5) Ioxilan;

(490.7) Ipilimumab;

Ipodate;

(491.5) Ipratropium;

(491.6) Irbesartan;

(491.7) Irinotecan;

Iron cacodylate;

Iron dextran injection;

Iron peptonized;

Iron sorbitex;

(495.3) Isatuximab;

(495.5) Isavuconazonium;

Isocarboxazid;

Isoetharine;

Isoflurane;

Isoflurophate;

Isometheptene;

Isoniazid;

Isopropamide;

Isoproterenol;

Isosorbide dinitrate;

(504.05) Isosorbide mononitrate;

(504.1) Isosulfan blue;

Isothipendyl;

(505.5) Isotretinoin;

Isoxsuprine;

(506.5) Isradipine;

(506.6) Istradefylline;

(506.7) Itraconazole;

(506.72) Ivabradine;

(506.75) Ivacaftor;

(506.8) Ivermectin - See exceptions;

(506.85) Ivosidenib;

(506.9) Ixabepilone;

(506.95) Ixazomib;

(506.97) Ixekizumab;

Kanamycin;

Reserved;

Ketocholanic acids;

(509.1) Ketoconazole - See exceptions;

(509.15) Ketoprofen - See exceptions;

(509.17) Ketorolac tromethamine;

(509.18) Ketotifen - See exceptions;

(509.2) Labetalol;

(509.7) Reserved;

Lactated ringers solution;

(510.5) Lactitol;

Lactulose;

(511.3) Lamivudine;

(511.5) Lamotrigine;

(511.55) Lanadelumab;

Lanatoside C;

(512.3) Lanreotide;

(512.5) Lansoprazole - See exceptions;

(512.6) Lanthanum;

(512.67) Lapatinib;

(512.69) Larotrectinib;

(512.691) Reserved;

(512.7) Latanoprost;

(512.8) Latanoprostene bunod;

Latrodectus mactans;

(513.3) Ledipasvir;

(513.4) Lefamulin;

(513.5) Leflunomide;

(513.7) Lenalidomide;

(513.74) Lenvatinib;

(513.77) Lesinurad;

(513.78) Letermovir;

(513.8) Letrozole;

Leucovorin;

(514.1) Leuprolide;

(514.5) Levalbuterol;

Reserved;

(515.5) Levamisole;

Levarterenol;

(516.05) Levetiracetam;

(516.07) Levobetaxolol;

(516.1) Levobunolol;

(516.3) Levobupivacine;

(516.5) Levocabastine;

(516.7) Levocarnitine;

(516.75) Levocetirizine dihydrochloride - See exceptions;

Levodopa;

(517.2) Levofloxacin;

(517.25) Levoleucovorin;

(517.3) Levomethadyl;

(517.35) Levomilnacipran;

(517.4) Levonordefrin;

Levopropoxyphene;

Levothyroxine;

Lidocaine - See exceptions;

(520.2) Lifitegrast;

(520.3) Linaclotide;

(520.5) Linagliptin;

Lincomycin;

Lindane - See exceptions;

(522.5) Linezolid;

Linolenic acid;

Liothyronine;

Liotrix;

(525.2) Liraglutide;

(525.5) Lisinopril;

Lithium carbonate - See exceptions;

Lithium citrate;

Liver extract;

(528.1) Lixisenatide;

(528.3) Lodoxamide;

(528.4) Lofexidine hydrochloride;

(528.5) Lomefloxacin;

(528.7) Lomitapide;

Lomustine;

(529.05) Lonafarnib;

(529.1) Loperamide - See exceptions;

(529.5) Lopinavir;

(529.7) Loracarbef;

(529.9) Loratadine - See exceptions;

(529.93) Reserved;

(529.94) Lorlatinib;

(529.95) Losartan;

(529.97) Loteprednol;

Lovastatin;

(530.5) Loxapine;

(530.7) Lubiprostone;

(530.8) Lucinactant;

Lugols solution;

(531.3) Luliconazole;

(531.4) Lumacaftor;

(531.43) Lumasiran;

(531.45) Lumateperone tosylate;

(531.5) Lumefantrine;

(531.7) Lurasidone;

(531.73) Lurbinectedin;

(531.75) Luspatercept-aamt;

(531.8) Lusutrombopag;

(531.9) Lutetium Lu 177 dotatate;

Lututrin;

Lymphogranuloma venereum antigen;

Lypressin synthetic;

(534.3) Macimorelin;

(534.5) Macitentan;

Mafenide;

(535.5) Maftivimab;

Magnesium gluconate - See exceptions;

Magnesium salicylate;

Mandelic acid - See exceptions;

Mannitol - See exceptions;

Mannitol hexanitrate;

(540.1) Maprotiline;

(540.3) Maraviroc;

(540.4) Margetuximab - anti HER2 mAb;

(540.5) Masoprocol;

Measles immune globulin, Human;

Measles virus vaccines;

Mebendazole for human use;

Mecamylamine;

(544.5) Mecasermin;

Mechlorethamine;

Meclizine - See exceptions;

(546.5) Meclocycline;

Meclofenamate;

Medroxyprogesterone;

Medrysone;

Mefenamic acid;

(550.5) Mefloguine;

Megestrol;

Meglumine;

(552.5) Meloxicam;

Melphalan;

(553.5) Memantine;

Menadiol;

Menadione;

Meningococcal polysaccharide vaccine;

Menotropins;

Mepenzolate;

Mephenesin;

Mephentermine;

Mephenytoin;

Mepivacaine;

(562.5) Mepolizumab;

Meprednisone;

(563.5) Mequinol;

Meralluride;

Mercaptomerin;

Mercaptopurine;

Mercury bichloride - See exceptions;

(567.1) Meropenem;

(567.2) Mersalyl;

(567.3) Mesalamine;

(567.5) Mesna;

Mesoridazine;

Mestranol;

Metaproterenol;

Metaraminol;

Metaxalone;

(572.5) Metformin;

Methacholine;

Methacycline;

Methallenestril;

Reserved;

Reserved;

Methantheline;

Methazolamide;

Methdilazine;

Methenamine hippurate;

Methenamine mandelate;

Methenamine sulfosalicylate;

Methicillin;

Methimazole;

Methiodal;

Methionine;

Methixene;

Methocarbamol;

Methotrexate;

Methotrimeprazine;

Methoxamine;

Methoxsalen;

Methoxyflurane;

Methoxyphenamine;

(595.5) Methoxy polyethylene glycol-epoetin beta;

Methscopolamine;

Methsuximide;

Methyclothiazide;

Methylandrostenediol;

Methylatropine;

Methyldopa;

Methyldopate;

Methylene blue, Oral;

Methylergonovine;

(604.5) Methylnaltrexone;

Methylprednisolone;

Reserved;

Methysergide;

Metoclopramide;

Metocurine iodide injection;

Metolazone;

Metoprolol;

(611.5) Metreleptin;

Metrizamide;

(612.5) Metrizoate;

Metronidazole;

Metyrapone;

Metyrosine;

(615.01) Mexiletine;

(615.1) Mezlocillin;

(615.6) Mibefradil;

(615.9) Micafungin;

Miconazole - See exceptions;

Microfibrillar collagen hemostat;

(617.1) Midodrine;

(617.2) Midostaurin;

(617.22) Midubosathol;

(617.3) Mifepristone;

(617.35) Migalastat;

(617.4) Miglitol;

(617.44) Miglustat;

(617.47) Milnacipran;

(617.5) Milrinone;

(617.7) Miltefosine;

Minocycline;

Minoxidil - See exceptions;

(619.05) Mipomersen;

(619.1) Mirabegron;

(619.3) Mirtazapine;

(619.5) Misoprostol;

Mithramycin;

Mitomycin;

Mitotane;

(622.3) Mitoxantrone;

(622.5) Mivacurium;

(622.7) Moexipril;

(622.8) Mogamulizumab;

Molindone;

(623.5) Mometasone;

Monobenzone;

(624.1) Monooctanoin;

(624.5) Montelukast;

(624.7) Moricizine;

Morrhuate;

(625.1) Moxalactam;

(625.2) Moxetumomab pasudotox-tdfk;

(625.3) Moxidectin;

(625.5) Moxifloxacin;

Mumps virus vaccines;

(626.5) Mupirocin;

Mushroom spores which, when mature, contain either psilocybin or psilocin;

(627.5) Mycophenolate;

N-acetyl-1-cysteine;

N. cattarhalis antigen;

(629.5) Nabumetone;

Nadolol;

(630.5) Nafarelin;

Nafcillin;

(631.5) Naftifine;

Nalbuphine;

(632.1) Naldemedine;

Reserved;

Nalidixic acid;

(634.5) Nalmefene;

(634.7) Naloxegol;

Naloxone - See exceptions;

(635.1) Naltrexone;

Reserved;

Naphazoline - See exceptions;

Naproxen - See exceptions;

(638.3) Naratriptan;

(638.4) Natalizumab;

(638.43) Naxitamab-gqgk;

(638.45) Nebivolol;

(638.47) Necitumumab;

(638.5) Nedocromil;

(638.7) Nefazodone;

(638.75) Nelarabine;

(638.8) Nelfinavir;

Neomycin - See exceptions;

Neostigmine;

(640.1) Nepafenac;

(640.11) Neratinib maleate;

(640.2) Nesiritide;

(640.25) Netarsudil;

(640.3) Netilmicin;

(640.35) Netupitant;

(640.4) Nevirapine;

(640.5) Niacinamide - See exceptions;

(640.7) Nicardipine;

(640.8) Niclosamide;

(641.1) Nicotine resin complex (polacrilex) - See exceptions;

(641.15) Nicotine transdermal system - See exceptions;

Nicotinyl alcohol;

(642.1) Nifedipine;

Nifuroximine;

(643.5) Nifurtimox;

Nikethamide;

(644.3) Nilotinib;

(644.4) Nilutamide;

(644.5) Nimodipine;

(644.6) Nintedanib;

(644.61) Niraparib;

(644.7) Nisoldipine;

(644.72) Nitazoxanide;

(644.8) Nitisinone;

(644.9) Nitric oxide - for use in humans;

Nitrofurantoin;

Nitrofurazone;

Nitroglycerin;

Nitroprusside - See exceptions;

(648.3) Nitrous oxide - See exceptions;

(648.5) Nivolumab;

(648.6) Nizatidine - See exceptions;

(649.1) Nomifensine maleate;

Nonoxynol - See exceptions;

Norepinephrine;

Norethindrone;

Norethynodrel;

(653.5) Norfloxacin;

Norgestrel;

Normal serum albumin, Human;

Nortriptyline;

Nositol;

Novobiocin;

(658.7) Nusinersen;

Nux vomica;

Nylidrin;

Nystatin;

(661.03) Obeticholic acid;

(661.05) Obiltoxaximab;

(661.1) Obinutuzumab;

(661.15) Ocilizumab;

(661.2) Ocrelizumab;

(661.3) Ocriplasmin;

(661.5) Octreotide acetate;

(661.55) Odesivimab-ebgn;

(661.6) Ofatumumab;

(661.7) Ofloxacin;

(661.8) Olanzapine;

(661.9) Olaparib;

(661.96) Olaratumab;

Old tuberculin;

Oleandomycin;

(663.1) Olmesartan;

(663.15) Olodaterol;

(663.2) Olopatadine - See exceptions;

(663.3) Olsalazine Sodium;

(663.35) Omacetaxine mepesuccinate;

(663.355) Omadacycline;

(663.36) Omalizumab;

(663.37) Ombitasvir;

(663.4) Omega-3-acid;

(663.5) Omeprazole - See exceptions;

(663.6) OnabotulinumtoxinA;

(663.7) Ondansetron;

(663.71) Opicapone;

(663.73) Oritavancin;

(663.75) Orlistat - See exceptions;

Orphenadrine;

Orthoiodobenzoic acid;

(665.5) Oseltamivir;

(665.53) Osilodrostat;

(665.55) Osimertinib;

(665.6) Ospemifene;

(665.7) Ovine hyaluronidase;

Oxacillin;

(666.4) Oxaliplatin;

(666.6) Oxamniquine;

Oxaprozin;

(667.5) Oxcarbazepine;

Oxethazaine;

(668.5) Oxiconazole;

Oxolinic acid;

(669.1) Oxprenolol;

Oxtriphylline;

Oxybutynin - See exceptions;

Oxygen for human use - See exceptions;

Oxymetazoline;

Oxyphenbutazone;

Oxyphencyclimine;

Oxyphenisatin;

Oxyphenonium;

Oxyquinoline;

Oxytetracycline;

Oxytocin;

(680.1) Ozanimod;

(680.3) Ozenoxacin;

(680.5) Ozogamicin;

P-nitrosulfathiazole;

(681.3) Paclitaxel;

(681.35) Palbociclib;

(681.4) Palifermin;

(681.45) Paliperidone;

(681.5) Palonosetron;

(681.7) Pamidronate;

Pancreatin dornase;

Pancreatic enzyme;

Pancrelipase;

Pancuronium;

(685.5) Panidronate;

(685.6) Panitumumab;

(685.65) Panobinostat;

(685.7) Pantoprazole;

Papaverine;

Paramethadione;

Paramethasone;

Paranitrosulfathiazole;

Parathyroid injection;

Pargyline;

(691.5) Paricalcitol;

(691.7) Paritaprevir;

Paromomycin;

(692.2) Paroxetine;

(692.25) Pasereotide;

(692.28) Pasireotide;

(692.29) Patiromer;

(692.295) Patisiran;

(692.3) Pazopanib;

(692.4) Pegademase bovine;

(692.5) Pegaspargase;

(692.51) Pegfilgrastin;

(692.513) Peginesatide;

(692.515) Peginterferon;

(692.517) Pegloticase;

(692.519) Pegvaliase-pqpz;

(692.52) Pegvisomant;

(692.53) Pembrolizumab;

(692.54) Pemetrexed;

(692.545) Pemigatinib;

(692.55) Pemirolast;

(692.6) Penbutolol;

(692.8) Penciclovir;

Penicillamine;

Penicillin;

Penicillin G;

Penicillin O;

Penicillin V;

Penicillinase;

Pentaerythritol tetranitrate;

Pentagastrin;

(700.1) Pentamidine isethionate;

Pentapiperide;

(701.5) Pentetate calcium trisodium;

(701.7) Pentetate zinc trisodium;

Penthienate;

Pentolinium;

(703.03) Pentosan;

(703.05) Pentostatin;

(703.1) Pentoxifylline;

(703.4) Pentylenetetrazol;

(703.42) Peramivir;

(703.43) Reserved;

(703.45) Perflexane;

(703.5) Perflubron;

(703.6) Perfluoroalkylpolyether;

(703.65) Perflutren;

(703.7) Pergolide;

Perindopril;

(704.1) Permethrin - See exceptions;

Perphenazine;

Pertussis immune globulin, Human;

(706.5) Pertuzumab;

(706.7) Pexidartinib;

Phenacemide;

Phenaglycodol;

Phenaphthazine;

Phenazopyridine - See exceptions;

Phenelzine;

Phenethicillin;

Phenformin;

Phenindamine;

Phenindione;

Pheniramine - See exceptions;

Phenitramin;

Phenothiazine derivatives;

Phenoxybenzamine;

Phenoxymethyl penicillin;

Phenuprocoumon;

Phensuximide;

Phentolamine;

Phenylbutazone;

Phenylmercuric acetate;

Phenylmercuric nitrate;

(726.5) Phenylpropanolamine;

Phenyltoloxamine dihydrogen citrate;

(727.2) Phenytoin;

Phthalylsulfacetamide;

Phthalylsulfathiazole;

Physostigmine;

Phytonadione;

(731.01) Pibrentasvir;

(731.1) Pimozide;

Pilocarpine;

(732.3) Pinacidil;

(732.7) Pindolol;

(732.8) Pioglitazone;

(732.9) Pimecrolimus;

Pipazethate;

(733.5) Pipecuronium;

Pipenzolate;

Piperacetazine;

(735.1) Piperacillin;

Piperazine;

Piperidolate;

Piperocaine;

Pipobraman;

Pipradrol;

(740.05) Pirbuterol;

(740.07) Pirfenidone;

(740.1) Piroxicam;

(740.5) Pitavastatin;

(740.7) Pitolisant;

Plague vaccine;

Plasma protein fraction;

(742.05) Plazomicin;

(742.1) Plecanatide;

(742.3) Plerixafor;

(742.5) Plicamycin;

Pneumococcal polyvalent vaccine;

(743.3) Podofilox;

(743.5) Podophyllotoxin;

Poison ivy extract;

Poison ivy oak extract;

Poison ivy oak, sumac extract;

(746.5) Polatuzumab vedotin-piiq;

Poldine methylsulfate;

(747.4) Polidocanol;

Poliomyelitis vaccine;

Poliovirus vaccine, Live, Oral, All;

Polyestradiol;

Polymyxin B - See exceptions;

(751.5) Polytetrafluoroethylene;

Polythiazide;

(752.05) Pomalidomide;

(752.1) Ponatinib;

(752.2) Poractant alfa;

(752.5) Porfimer;

(752.7) Posaconazole;

Posterior pituitary;

Potassium acetate injection;

Potassium acid phosphate - See exceptions;

Potassium p-aminobenzoate - See exceptions;

Potassium aminosalicylate - See exceptions;

Potassium arsenite - See exceptions;

Potassium bicarbonate - See exceptions;

Potassium carbonate - See exceptions;

Potassium chloride - See exceptions;

Potassium citrate - See exceptions;

Potassium gluconate - See exceptions;

Potassium hetacillin;

Potassium iodide - See exceptions;

Reserved;

Potassium permanganate - See exceptions;

Povidone - Iodine - See exceptions;

(768.5) PrabotulinumtoxinA-xvfs;

(768.8) Pralatrexate;

Pralidoxime;

(769.1) Pralsetinib;

(769.2) Pramipexole;

(769.3) Pramlintide;

(769.33) Prasterone;

(769.35) Prasugrel;

(769.4) Pravastatin;

(769.7) Praziquantel;

Prazosin;

(770.5) Prednicarbate;

Prednisolone;

Prednisone;

(772.5) Pretomanid;

Prilocaine;

Primaquine;

Primidone;

Probenecid;

Probucol;

Procainamide;

Procaine;

Procaine penicillin;

Procaine penicillin G;

Procarbazine;

Prochlorperazine;

Procyclidine;

Progesterone;

(785.5) Proguanil;

Promazine;

Promethazine;

Promethestrol;

(788.5) Propafenone;

Propantheline;

Proparacaine;

Prophenpyridamine - See exceptions;

Propiolactone;

Propiomazine;

Propoxycaine;

Propranolol;

(795.5) Propylhexedrine;

Propylparaben;

Propylthiouracil;

Protamine sulfate injection;

Protein hydrolysate injection;

Protein, Foreign injection;

Proteolytic enzyme;

Protirelin;

Protokylol;

Protoveratrine A and B;

Protriptyline;

(805.3) Prucalopride;

(805.5) Prussian blue;

Reserved;

Pseudomonas polysaccharide complex;

P-ureidobenzenearsonic acid;

Purified protein derivatives of tuberculin;

Pyrantel;

Pyrazinamide;

Pyrazolon;

Pyridostigmine;

Pyrimethamine;

Pyrrobutamine;

Pyrvinium;

(816.5) Quetiapine;

Quinacrine;

(817.5) Quinapril;

Quinestrol;

Quinethazone;

Quinidine;

Quinine hydrochloride;

Quinine and urea hydrochloride;

(822.3) Quinupristin;

(822.5) Rabeprazole;

Rabies anti-serum;

Rabies immune globulin, Human;

Rabies vaccine;

Radio-iodinated compounds;

Radio-iodine;

Radio-iron;

Radioisotopes;

Radiopaque media;

Ragweed pollen extract;

(831.02) Raloxifene;

(831.03) Raltegravir;

(831.04) Ramelteon;

(831.05) Ramipril;

(831.06) Ramucirumab;

(831.07) Ranibizumab;

(831.1) Ranitidine - See exceptions;

(831.3) Ranolazine;

(831.5) Rapacuronium;

(831.7) Rasagiline;

Rauwolfia serpentina;

(832.05) Ravulizumab;

(832.1) Raxibacumab;

(832.2) Reboparhamil;

(832.5) Regadenoson;

(832.7) Regorafenib;

(832.9) Relebactam;

(832.95) Relugolix;

(832.97) Remdesivir;

Rescinnamine;

Reserpine;

Reserpine alkaloids;

(835.5) Reslizumab;

Resorcinol monoacetate - See exceptions;

(836.3) Retapamulin;

(836.5) Retinoic acid, all-trans;

(836.7) Revefenacin;

Rhus toxicodendron antigen;

Rh D immune globulin, Human;

(838.5) Ribavirin;

(838.6) Ribociclib;

Riboflavin - See exceptions;

Ricinoleic acid;

(840.5) Rifabutin;

Reserved;

Rifampin;

(842.05) Rifamycin;

(842.1) Rifapentine;

(842.15) Rifaximin;

(842.17) Rilonacept;

(842.18)Rilpivirine;

(842.2) Riluzole;

(842.4) Rimantadine;

(842.5) Rimegepant;

(842.7) Rimexolone;

Ringer's injection;

(843.1) Riociguat;

(843.13) Ripretinib;

(843.15) Risankizumab-rzaa;

(843.17) Risdiplam;

(843.2) Risedronate;

(843.3) Risperidone;

(843.7) Ritodrine;

(843.8) Ritonavir;

(843.82) Rituximab;

(843.825)Rivaroxaban;

(843.83) Rivastigmine;

(843.9) Rizatritpan;

Rocky mountain spotted fever vaccine;

(844.5) Rocuronium;

(844.7) Rofecoxib;

(844.75) Roflumilast;

(844.8) Rolapitant;

Rolitetracycline;

(845.1) Romidepsin;

(845.15) Romiplostim;

(845.2) Romosozumab-aqqg;

(845.3) Ropinirole;

(845.5) Ropivacaine;

(845.7) Rosiglitazone;

(845.8) Rosuvastatin;

(845.9) Rotavirus vaccine;

(845.95) Rotigotine;

Rotoxamine;

(846.5) RSVIGIV;

Rubella and mumps virus vaccine;

Rubella virus vaccine;

(848.2) Rucaparib;

(848.5) Rufinamide;

Rutin - See exceptions;

(849.3) Sacituzumab govitecan-hziy;

(849.5) Sacrosidase;

(849.7) Sacubitril;

(849.8) Safinamide;

Salicylazosulfapyridine;

(850.5) Salmeterol;

Salmonella typhosa, Killed;

(851.02) Reserved;

(851.03) Samarium SM 153 lexidronam;

(851.04) Saneromazile;

(851.045) Sapropterin;

(851.05) Saquinavir;

(851.1) Saralasin acetate;

(851.15) Sarecycline;

(851.2) Sarilumab;

(851.5) Satralizumab-mwge;

(851.7) Saxagliptin;

Scopolamine;

(852.05) Sebelipase;

(852.06) Secnidazole;

(852.1) Secretin;

(852.4) Secukinumab;

(852.5) Segesterone acetate;

(852.6) Selegiline;

Selenium sulfide - See exceptions;

(853.5) Selenomethionine;

(853.7) Selexipag;

(853.8) Selinexor;

(853.85) Selpercatinib;

(853.87) Selumetinib;

(853.9) Semaglutide;

Senecio cineraria extract ophthalmic solution;

Senega fluid extract;

(855.3) Seractide acetate;

(855.5) Sermorelin Acetate;

(855.6) Sertaconazole;

(855.7) Sertraline;

(855.73) Setmelanotide;

(855.74) Sevelamer;

(855.8) Sevoflurane;

(855.85) Sildenafil;

(855.9) Silodosin;

(855.95) Siltuximab;

Silver nitrate ophthalmic solutions or suspensions;

Silver sulfadiazine cream;

(857.1) Simeprevir;

(857.3) Simethicone coated cellulose suspension;

(857.5) Simvastatin;

Sincalide;

(858.3) Sinecatechins;

(858.4) Siponimod;

(858.5) Sirolimus;

(858.7) Sitagliptin;

Sitosterols;

Solutions for injections, All;

Smallpox vaccine;

Sodium acetate injection;

Sodium acetrizoate;

Sodium ascorbate injection;

Sodium biphosphate - See exceptions;

Sodium cacodylate;

Sodium chloride injection - See exceptions;

Sodium dehydrocholate;

Sodium dextrothyroxine;

Sodium estrone;

Sodium fluorescein - See exceptions;

Sodium fluoride - See exceptions;

Sodium iothalamate;

(873.5) Sodium nitroprusside;

(873.7) Sodium phenylbutyrate;

(873.8) Sodium picosulfate;

Sodium polystyrene sulfonate;

Sodium propionated vaginal cream;

Sodium sulfacetamide;

Sodium sulfadiazine;

Sodium sulfobromophthalein;

Sodium sulfoxone;

Sodium tetradecyl;

(880.5) Sodium thiosulfate;

Sodium tyropanoate;

(881.01) Sodium zirconium cyclosilicate;

(881.03) Sofosbuvir;

(881.05) Solifenacin;

(881.07) Somapacitan-beco;

(881.1) Somatrem;

Somatropin;

(882.3) Sonidegib;

(882.5) Sorafenib;

Sorbus extract;

(883.5) Sotalol;

(883.8) Sparfloxacin;

Sparteine;

Spectinomycin;

(885.5) Spinosad;

Spirapril;

Spironolactone;

Staphage lysate bacterial antigen;

Staphylococcus and streptococcus vaccine;

Staphylococcus toxoid;

(890.5) Stavudine;

Stibophen;

Stinging insect antigens - Combined;

(892.5) Stiripentol;

Stockes expectorant;

Stramonium;

Streptococcus antigen;

Streptokinase-streptodornase;

Streptomycin;

Strontium - See exceptions;

Strophanthin-G;

Strychnine - See exceptions;

Succimer;

Succinylchloline;

Succinylsulfathiazole;

(903.1) Sucralfate;

(903.15) Sucroferric oxyhydroxide;

(903.17) Sugammadex;

(903.2) Sulconazole;

Sulfabenzamide vaginal preparations;

Sulfacetamide;

Sulfachlorpyridazine;

Sulfacytine;

Sulfadiazine;

Sulfadimethoxine;

(909.1) Sulfadoxine;

Sulfaethidole;

Sulfaguanidine;

Sulfamerazine;

Sulfameter;

Sulfamethazine;

Sulfamethizole;

Sulfamethoxazole;

Sulfamethoxypyridazine;

Sulfanilamide;

Sulfaphenazole;

Reserved;

Sulfapyridine;

Sulfasalazine;

(922.5) Sulfathiazole;

Sulfinpyrazone;

Sulfisomidine;

Sulfisoxazole;

Sulfur thioglycerol;

Sulindac;

(927.5) Sumatriptan;

(927.7) Sunitinib;

Superinone;

(928.1) Suprofen;

Sutilains;

Syrosingopine;

(930.5) Tacrine;

(930.7) Tacrolimus;

(930.9) Tadalafil;

(930.901) Tafamidis meglumine;

(930.905) Tafasitamab-cxix;

(930.91) Tafenoquine;

(930.93) Tafluprost;

(930.97) Tagliglucerase alfa;

(930.975) Tagraxofusp-erzs;

(930.976) Talazoparib;

(930.98) Talimogene;

Tamoxifen;

(931.1) Tamsulosin;

(931.2) Tasimelteon;

(931.21) Tavaborole;

(931.3) Tazarotene;

(931.33) Tazemetostat;

(931.35) Tazobactam;

(931.37) Tbo-filgrastim;

(931.5) Technetium;

(931.51) Tecovirimat;

(931.52) Tedizolid;

(931.53) Teduglutide;

(931.55) Tegaserod;

(931.553) Telaprevir;

(931.555) Telavancin;

(931.56) Telbivudine;

(931.57) Telithromycin;

(931.6) Telmisartan;

(931.61) Telotristat ethyl;

(931.7) Temafloxacin;

(931.75) Temozolomide;

(931.77) Temsirolimus;

(931.79) Tenapanor;

(931.8) Teniposide;

(931.83) Teprotumumab-trbw;

(931.85) Terazosin;

(931.9) Tenofovir;

(931.95) Terbinafine - See exceptions;

Terbutaline;

(932.05) Terconazole;

(932.1) Terfenadine;

(932.2) Teriflunomide;

(932.3) Teriparatide;

Terpin hydrate with codeine;

Reserved;

Tesamorelin;

Tetanus and diphtheria toxoids;

Tetanus antitoxin;

Tetanus immune globulin;

Tetanus toxoids;

(939.5) Tetrabenazine;

Tetracaine;

Tetracycline;

Tetraethylammonium chloride;

Tetrahydrozoline - See exceptions;

(943.3) Tezacaftor;

(943.5) Thalidomide;

Thallous chloride;

Theobromide;

(945.5) Reserved;

Theobromine magnesium oleate;

Theophylline - See exceptions;

Theophylline sodium glycinate;

Thiabendazole;

Thiamylal;

Thiethylperazine;

Thiopropazate;

Thioguanine;

Thioridazine;

Thiosalicylate;

Thiotepa;

Thiothixene;

Thiphenamil;

Thrombin;

Thyroglobulin;

Thyroid;

Thyrotropin;

Thyroxine;

Thyroxine fraction;

(964.5) Tiagabine;

(964.7) Ticagrelor;

Ticarcillin;

(965.5) Ticlopidine;

Ticrynafen;

(966.3) Tigecycline;

(966.5) Tildrakizumab;

(966.6) Tiludronate;

Timolol;

(967.1) Tinidazole;

(967.2) Tinzaparin;

(967.3) Tioconazole - See exceptions;

(967.5) Tiopronin;

(967.55) Tiotropium;

(967.56) Tipiracil;

(967.57) Tipranavir;

(967.58) Tirbanibulin;

(967.6) Tirofiban;

(967.7) Tizanidine;

Tobramycin;

(968.1) Tocainide;

Tocamphyl;

(969.6) Tocilizumab;

(969.8) Tofacitinib;

Tolazamide;

Tolazoline;

Tolbutamide;

(972.5) Tolcapone;

Tolmetin;

(973.05) Tolterodine;

(973.07) Tolvaptan;

(973.1) Topiramate;

(973.3) Topotecan;

(973.4) Toremifene;

(973.5) Torsemide;

(973.6) Trabectedin;

(973.7) Trametinib;

(973.8) Trandolapril;

(973.9) Tranexamic acid;

Tranylcypromine;

(974.2) Trastuzumab;

(974.4) Travoprost;

(974.5) Trazodone;

(974.7) Treprostinil;

Tretinoin;

Triamcinolone - See exceptions;

Triamterene;

Trichlormethiazide;

Trichloroacetic acid - See exceptions;

Trichloroethylene - See exceptions;

Trichlobisonium;

(981.5) Triclabendazole;

Triclofos;

Tridihexethyl chloride;

(983.1) Trientine;

Triethanolamine polypeptides;

Triethylenethiophosphoramide;

(985.5) Trifarotene;

Trifluoperazine;

Triflupromazine;

Trifluridine;

(988.5) Triheptanoin;

Trihexyphenidyl;

Triiodothyronine;

(990.1) Trilostane;

Trimeprazine;

Trimethadione;

Trimethaphan cansylate;

Trimethobenzamide;

Trimethoprim;

(995.5) Trimetrexate;

Trimipramine;

Triolein;

Trioxsalen;

Tripelennamine - See exceptions;

Triphenyltetrazolium;

Triple sulfas;

Triprolidine - See exceptions;

(1002.5) Triptorelin;

Trisulfapyrimidines;

(1003.5) Troglitazone;

Troleandomycin;

Trolnitrate;

Tromethamine;

Tropicamide;

(1007.3) Trospium;

(1007.5) Trovafloxacin;

Trypsin;

Trypsin-chymotrypsin;

Tuaminoheptane;

Tuberculin, Purified protein derivatives;

Tuberculin tine test;

Tuberculin, Old;

Tubocurarine;

(1014.5) Tucatinib;

Tybamate;

Typhoid and paratyphoid vaccine;

Typhus vaccine;

Tyropanoate;

(1018.3) Ubrogepant;

(1018.5) Ulipristal;

(1018.8) Umeclidinium;

Undecoylium;

(1019.5) Unoprostone;

(1019.7) Upadacitinib;

Uracil;

Urea - See exceptions;

(1021.1) Uridine;

(1021.3) Urofollitropin;

(1021.5) Ursodiol;

(1021.6)Ustekinumab;

(1021.61)Vaborbactam;

(1021.7) Valacyclovir;

(1021.71) Valbenazine;

(1021.8) Valdecoxib;

Valethamate;

(1022.2) Valganciclovir;

Valproate;

Valproic acid - See exceptions;

(1024.3) Valrubicin;

(1024.5) Valsartan;

Vancomycin;

(1025.2) Vandetanib;

(1025.5) Vardenafil;

(1025.7) Varenicline;

Vasopressin;

VDRL antigen;

(1027.1) Vecuronium bromide;

(1027.2) Vedolizumab;

(1027.3) Velaglucerase;

(1027.5) Velnacrine;

(1027.53) Velpatasvir;

(1027.55) Vemuranfenib;

(1027.57) Venetoclax;

(1027.6) Venlafaxine;

(1027.7) Verapamil;

Veratrum viride;

Versenate;

(1029.5) Verteporfin;

(1029.6) Vestronidase alfa-vjbk;

(1029.8) Vibegron;

Vidarabine;

(1030.3)Vigabatrin;

(1030.4) Vilanterol;

(1030.5) Vilazodone;

(1030.7) Viltolarsen;

Vinblastine;

Vincristine;

(1032.5) Vinorelbine;

Vinyl ethyl - See exceptions;

Viomycin;

(1034.5) Vismodegib;

Vitamin K;

Vitamin B12 injection;

Vitamine with fluoride;

(1037.3) Vorapaxar;

(1037.5) Voriconazole;

(1037.7) Vorinostat;

(1037.8) Vortioxetine;

(1037.85) Voxelotor;

(1037.9) Voxilaprevir;

Warfarin;

Wargarin;

(1039.1) Xylocaine;

Yellow fever vaccine;

Yohimbine;

4-chloro-3, 5-xylenol - See exceptions;

(1042.01) Zafirlukast;

(1042.02) Zalcitabine;

(1042.03) Zanamivir;

(1042.04) Zanubrutinib;

(1042.05) Zidovudine;

(1042.4) Zileuton;

(1042.7) Zinc acetate - See exceptions;

(1042.75) Ziprasidone;

(1042.78) Ziv-aflibercept;

(1042.8) Zoledronic Acid;

(1042.9) Zolmitriptan;

(1042.92) Zonisamide;

Devices that require a prescription:

Cellulose, Oxadized, Regenerated (surgical absorbable hemostat) - See exceptions;

Diaphragms for vaginal use;

Hemodialysis solutions;

Hemodialysis kits;

Lippes loop intrauterine;

Saf-T-Coil intrauterine device;

Intrauterine devices, All;

Absorbable hemostat;

Gonorrhea test kit.

(b.1)A "restricted dangerous drug" means any other drug or substance declared by the General Assembly to have no medical use, which cannot be legally prescribed by a practitioner, and which cannot be manufactured, grown, produced, distributed, used, or otherwise possessed in this state; to include any of the following drugs, chemicals, or substances; salts, isomers, esters, ethers, or derivatives of such drugs, chemicals, or substances which have essentially the same pharmacological action; and all other salts, isomers, esters, ethers, and compounds of such drugs, chemicals, or substances unless specifically exempted, identified as "restricted dangerous drugs":

1. Salvinorin A; and
2. Salvia divinorum - except as otherwise provided for in paragraph (4.3) of Code Section 16-13-72.

   This subsection shall not prohibit a person from possessing a restricted dangerous drug for the purpose of conducting research approved by the federal Food and Drug Administration.

   (0.5) Adapalene - when used with a strength up to 0.1 percent in a topical skin product;

3. Belladonna or belladonna alkaloids when in combination with other drugs and the dosage unit is less than 0.1 mg. of the alkaloids or its equivalent;

   (3.5) Bentoquatam - when used with a strength of 5 percent or less in topical preparations;

4. Beta carotene - all forms occurring in food products or lotions;
5. Bromelain, pancreatic enzymes, trypsin and bile extract - when labeled properly as digestive aids with appropriate dosage and in compliance with FDA labeling and restrictions;
6. Brompheniramine - where a single dosage unit is 4 mg. or less but with no more than 3 mg. of the dextrorotary optical isomer of racemic brompheniramine per released dose;

   (6.1) Budesonide - when used as a nasal spray in doses up to 32 mcg. per spray;

   (6.2) Butenafine - when used with a strength of 1 percent or less as a topical preparation;

   (6.4) Butoconazole - when used with a strength up to 2 percent in a vaginal preparation;

   (6.45) Capsaicin - when in an external analgesic with concentration of 0.25 percent or less;

   (6.5)Cetirizine - when a single dosage unit is either 1 mg. per 1 ml. or less or 10 mg. or less;

   (6.7) Chlorhexadine - when used with a strength up to 4 percent in a topical skin product;

7. Chlorpheniramine - where a single dosage unit is 12 mg. or less;

   (7.1) Cimetidine - when a single dosage unit is 200 mg. or less;

   (7.3) Clemastine - where a single dose is 1.34 mg. or less;

   (7.5) Clotrimazole - when a single vaginal insert is 200 mg. or less or with a strength up to 2 percent in a topical skin, topical vaginal, or vaginal product;

   (7.8) Cromolyn - when used as cromolyn sodium in a nasal solution of 4 percent or less in strength;

   (7.9) Dexbrompheniramine - when a single dosage unit is 6 mg. or less;

   (7.95) Diclofenac Sodium - When used with a strength of 1 percent or less in a topical gel;

8. Diphenhydramine - up to 12.5 mg. in each 5 cc's when used in cough preparations and up to 50 mg. per single dose when used as a nighttime sleep aid or used as an antihistamine and labeled in compliance with FDA requirements;

   (8.5) Docosanol - when used in 10 percent topical preparation to treat fever blisters, cold sores, or fever blisters and cold sores.

9. Doxylamine succinate - where a single dosage form is 25 mg. or less and when labeled to be used as a nighttime sedative;

   (9.3) Edetate - when used in any form other than an oral or parenteral;

   (9.33) Epinephrine - when used in a device that delivers a metered spray of 0.125 mg. of epinephrine or less to provide temporary relief for symptoms of mild, intermittent asthma and is a product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the U.S. Food and Drug Administration (FDA);

   (9.4) Esomeprazole - when a single dosage unit is 20 mg. or less;

   (9.5) Famotidine - when a single dosage unit is 20 mg. or less;

   (9.6) Fexofenadine - when packaged for distribution as an over-the-counter (OTC) drug product;

   (9.7) Fluoride - when used with a strength up to 1,500 parts per million in an oral care or dentifrice product;

   (9.75) Fluticasone - when available in a device that delivers a metered spray of 0.05 mg. and to be used for the temporary relief of symptoms due to hay fever or other upper respiratory allergies;

   (9.8) Glycine - when used with a strength up to 1.5 percent in an irrigation solution, when used in a topical skin product;

10. Hydrocortisone topical skin preparations up to 1 percent in strength;
11. Hydroxocobalamin, riboflavin, niacinamide, ergocalciferol (maximum of 400 I.U. per day), Folic acid (maximum of 0.4 mg. per day), and magnesium gluconate - when as a source of vitamins and dietary supplement but must bear such labels and adhere to such restrictions of FDA regulations;

    (11.1) Ibuprofen - where a single dose is 200 mg. or less;

    (11.6) Reserved;

12. Insulin - all injectable products which do not require a prescription drug order and bear a label which indicates "Rx Use Only" or are otherwise listed under subsection (b) of this Code section; and no injectable insulin product may be sold except by a pharmacy issued a permit by the State Board of Pharmacy or by a medical practitioner authorized to dispense medications;

    (12.1) Ivermectin - When used with a strength of 0.5 percent or less in a topical lotion;

    (12.3) Ketoconazole - when used with a strength of 1 percent or less in topical preparations;

    (12.5) Ketoprofen - when a single dosage unit is 12.5 mg. or less;

    (12.7) Ketotifen - when used with a strength of 0.025 percent or less in an ophthalmic solution;

    (12.9) Lansoprazole - when a single dosage unit is 15 mg. or less;

    (12.91) Levocetirizine - when a single dose unit is either 2.5 mg. per 5 ml. or less or 5 mg. or less;

    (12.95) Levocetirizine dihydrochloride - when used in a single dose of 5 mg. or less;

13. Lidocaine topical, 40 mg./gm. (4 percent) or less;

    (13.5) Loperamide - where a single dose is either 1 mg. per 5 ml. or 2 mg. per dosage unit;

    (13.7) Loratadine - when used in a single dose of 10 mg. or less, including doses used in combination with other drugs provided for under this subsection;

14. Meclizine - 25 mg. or less;

    (14.1) Miconazole - when used as antifungal powder or cream, or both, and containing not more than 4 percent of miconazole, or when used as a vaginal insert and containing not more than 1,200 mg. of miconazole;

    (14.2) Minoxidil - when used with a strength of 5 percent or less in topical preparations;

    (14.25) Naloxone - shall also be exempt from subsections (a) and (b) of this Code section when used for drug overdose prevention and when supplied by a dispenser or licensed distributor or wholesaler as follows:

    1. Nasal adaptor rescue kits containing a minimum of two prefilled 2 ml. luer-lock syringes with each containing 1 mg./ml. of naloxone;
    2. Prepackaged nasal spray rescue kits containing single-use spray devices with each containing a minimum of 4 mg./0.1 ml. of naloxone;
    3. Muscle rescue kits containing a 10 ml. multidose fliptop vial or two 1 ml. vials with a strength of 0.4 mg./ml. of naloxone; or
    4. Prepackaged kits of two muscle autoinjectors with each containing a minimum of 0.4 mg./ml. of naloxone;

    (14.3) Naphazoline - when used in an ophthalmic solution in a concentration of 0.027 percent or less in combination with a pheniramine concentration of 0.315 percent or less;

    (14.5) Naproxen - where a single dosage unit is 220 mg. or less;

15. Neomycin sulfate ointment or cream for topical use;

    (15.5) Nicotine resin complex (polacrilex) - when used as oral chewing gum where a single dose (piece of gum) is 4 mg. or less;

    (15.55) Nicotine transdermal system - when used in a strength of 21 mg. or less per transdermal patch (transdermal delivery system);

16. Nitrous oxide - air products suppliers shall not sell medical grade nitrous oxide to other than licensed practitioners or medical suppliers; industrial grade nitrous oxide shall only be sold when mixed with not less than 100 parts per million of sulfur dioxide and used as a fuel additive for combustion engines or when used in industrial laboratory equipment;

    (16.3) Nizatidine - when a single dosage unit is 75 mg. or less;

    (16.8) Nonoxynol - when used with a strength up to 12.5 percent or 1 gram per dose in a vaginal product;

    (16.85) Olopatadine hydrochloride - When used with a strength of 0.7 percent or less in an ophthalmic solution;

    (16.9) Omeprazole - when a single dosage unit is 20.6 mg. or less;

    (16.95) Orlistat - when a single dosage unit is 60 mg. or less;

    (16.97) Oxybutynin - when a single dose is delivered as 3.9 mg. per day using a transdermal system patch;

17. Oxygen - compressed oxygen which is not labeled "CAUTION: Federal law prohibits dispensing without prescription" or similar wording;

    (17.3) Permethrin - when used as a topical preparation in a strength of 1 percent or less;

    (17.5) Phenazopyridine - where a single dose is 100 mg. or less, as approved by the federal Food and Drug Administration;

18. Pheniramine - when the oral dose is 25 mg. or less, or when used in an ophthalmic solution in a concentration of 0.315 percent or less in combination with a naphazoline concentration of 0.027 percent or less;
19. Polymyxin B when in combination with other drugs in an ointment or cream for topical use;
20. Any potassium electrolyte when manufactured for use as a dietary supplement, food additive for industrial, scientific, or commercial use, or when added to other drug products when the product is not intended as a potassium supplement but must bear such labels and adhere to such restrictions of FDA regulations;
21. Povidone - Iodine solutions and suspensions;
22. Reserved;
23. Reserved;

    (23.5) Ranitidine - when a single dosage unit is 150 mg. or less;

24. Rutin - where the dosage unit is less than 60 mg.;
25. Selenium sulfide suspension 1 percent or less in strength;

    (25.05) Sodium chloride injection - when in quantities of 10 cc or less and used as a catheter flush solution to act by physically occupying space within a catheter and exerting pressure on the patient's circulating blood;

    (25.1) Strychnine - when used in combination with other active ingredients in a rodent killer, and when not bearing a label containing the words "CAUTION: Federal law prohibits dispensing without prescription" or other similar wording;

    (25.5) Terbinafine - when used with a strength of 1 percent or less in a topical antifungal cream;

26. Tetrahydrozoline for ophthalmic or topical use;
27. Theophylline preparations alone or in combination with other drugs prepared for and approved for OTC (over the counter) sale by FDA; example - tedral tablets (plain) or oral suspension;

    (27.5) Tioconazole - when used with a strength of 1 percent or less in topical preparations or when used with a strength of 6.5 percent or less in vaginal preparations;

    (27.7) Triamcinolone acetonide - when used in a nasal spray that delivers 55 mcg. per spray or less;

28. Tripelennamine cream or ointment for topical use;

    (28.5) Triprolidine - when a single dose is 5 mg. or less when combined in the same preparation as one or more other drug products for use as an antihistamine or decongestant or an antihistamine and decongestant;

29. Urea - except when the manufacturer's label contains the wording "CAUTION: Federal law prohibits dispensing without prescription" or similar wording;

    (29.5) Zinc acetate - when used in topical preparations;

30. Any drug approved by FDA for animal use and the package does not bear the statement "CAUTION: Federal law prohibits dispensing without prescription" or similar wording; or
31. Loperamide Oral Liquid (1.00 mg./5.00 ml.).
32. Mandelic acid;
33. Mannitol;
34. Mercury bichloride;
35. Nitroprusside;
36. Potassium aminosalicylate;
37. Potassium p-aminobenzoate;

    (37.5) Potassium perchlorate;

38. Potassium permanganate;
39. Resorcinol monoacetate;
40. Selenium sulfide;
41. Sodium biphosphate;
42. Sodium fluorescein;
43. Sodium fluoride;
44. Strontium;
45. Trichloroacetic acid;
46. Trichloroethylene;
47. Valproic acid;
48. Vinyl ether;
49. 4-chloro-3, 5-xylenol.

The following are exceptions to and exemptions from subsection (b) of this Code section:

Atropine sulfate - where the oral dose is less than 1/200 gr. per unit;

Bacitracin cream or ointment for topical use;

The following list of compounds or preparations may be purchased without a prescription, provided the products are manufactured for industrial, scientific, or commercial sale or use, unless they are intended for human use or contain on the label "CAUTION: Federal law prohibits dispensing without prescription" or similar wording:

Aminosalicylate;

Aminosalicylate calcium;

Aminosalicylate potassium;

Aminosalicylate sodium;

Aminosalicylic acid;

Barium;

Beta-carotene;

Bismuth sodium tartrate;

Cadmium sulfide;

Calcium disodium edetate;

Cellulose, Oxadized, Regenerated;

Chlorabutanol;

Chloranil;

Chloroacetic acid;

Chloroform;

Colchicine;

Dapsone;

Dimethyl sulfoxide;

Disodium edetate;

Edetate disodium;

Ether;

Ethoxazene;

Ethyl chloride;

Fluoride;

Formaldehyde;

Gold thiosulfate;

Hexachlorophene;

Iodobenzoic acid;

Iopanoic acid;

Lindane;

Lithium carbonate;

The State Board of Pharmacy may delete drugs from the dangerous drug list set forth in this Code section. In making such deletions the board shall consider, with respect to each drug, the following factors:

The actual or relative potential for abuse;

The scientific evidence of its pharmacological effect, if known;

The state of current scientific knowledge regarding the drug;

The history and current pattern of abuse, if any;

The scope, duration, and significance of abuse;

Reserved;

The potential of the drug to produce psychic or physiological dependence liability; and

Whether such drug is included under the federal Food, Drug, and Cosmetic Act, 52 Stat. 1040 (1938), 21 U.S.C. Section 301, et seq., as amended.

(Code 1933, § 79A-702, enacted by Ga. L. 1967, p. 296, § 1; Ga. L. 1972, p. 948, § 1; Ga. L. 1976, p. 631, § 1; Ga. L. 1978, p. 1668, § 5; Ga. L. 1979, p. 859, § 3; Ga. L. 1980, p. 1746, § 2; Ga. L. 1981, p. 557, § 2; Ga. L. 1982, p. 3, § 16; Ga. L. 1982, p. 2403, §§ 3-8, 20; Ga. L. 1983, p. 3, § 13; Ga. L. 1983, p. 349, §§ 3-6; Ga. L. 1984, p. 22, § 16; Ga. L. 1984, p. 1019, §§ 3-5; Ga. L. 1985, p. 1219, §§ 8, 9; Ga. L. 1986, p. 1555, §§ 6, 7; Ga. L. 1987, p. 261, § 7; Ga. L. 1989, p. 233, §§ 7, 8; Ga. L. 1990, p. 640, §§ 2, 3; Ga. L. 1991, p. 312, § 2; Ga. L. 1992, p. 6, § 16; Ga. L. 1992, p. 1131, §§ 5-7; Ga. L. 1993, p. 590, §§ 4-7; Ga. L. 1994, p. 169, §§ 6, 7; Ga. L. 1994, p. 849, § 1; Ga. L. 1996, p. 356, §§ 3-5; Ga. L. 1997, p. 1311, §§ 6-10; Ga. L. 1998, p. 778, §§ 3-6; Ga. L. 1999, p. 81, § 16; Ga. L. 1999, p. 643, §§ 2-5; Ga. L. 2000, p. 1317, §§ 4-6; Ga. L. 2001, p. 816, §§ 4-6; Ga. L. 2003, p. 349, §§ 8-11; Ga. L. 2004, p. 488, §§ 4-7; Ga. L. 2005, p. 1028, §§ 2, 3/SB 89; Ga. L. 2006, p. 219, §§ 3-5/HB 1054; Ga. L. 2007, p. 47, § 16/SB 103; Ga. L. 2007, p. 605, §§ 3-5/HB 286; Ga. L. 2008, p. 169, §§ 6, 7, 8/HB 1090; Ga. L. 2009, p. 126, § 5/HB 368; Ga. L. 2010, p. 860, §§ 5, 6, 7/SB 353; Ga. L. 2010, p. 905, § 1/HB 1021; Ga. L. 2011, p. 656, §§ 7-10/SB 93; Ga. L. 2012, p. 40, § 5/SB 370; Ga. L. 2013, p. 71, §§ 3, 4, 5/HB 302; Ga. L. 2014, p. 217, §§ 6, 7/HB 835; Ga. L. 2014, p. 866, § 16/SB 340; Ga. L. 2015, p. 5, § 16/HB 90; Ga. L. 2015, p. 883, §§ 5, 6/HB 211; Ga. L. 2016, p. 798, §§ 5-7, 8/HB 783; Ga. L. 2016, p. 864, § 16/HB 737; Ga. L. 2017, p. 14, §§ 9-11/HB 231; Ga. L. 2017, p. 22, §§ 2, 3/SB 121; Ga. L. 2017, p. 319, §§ 1-3, 1-4/HB 249; Ga. L. 2017, p. 774, § 16/HB 323; Ga. L. 2018, p. 314, §§ 6-9/HB 830; Ga. L. 2019, p. 820, §§ 4-12/HB 483; Ga. L. 2020, p. 16, §§ 2-4/HB 759; Ga. L. 2020, p. 55, § 1/SB 372; Ga. L. 2020, p. 493, § 16/SB 429; Ga. L. 2021, p. 386, §§ 8-10/HB 367; Ga. L. 2021, p. 922, § 16/HB 497.)

The 2016 amendments. The first 2016 amendment, effective May 3, 2016, in subsection (b), added " - See exceptions" at the end of paragraph (b)(115.3); deleted "succinate" following "Doxyla- mine" in paragraph (b)(323); substituted "Mepivacaine" for "Meprednisone" in paragraph (b)(562); substituted "Meprednisone" for "Mepivacaine" in paragraph (b)(563); and substituted "Reserved" for "Salvinorin A" in paragraph (b)(851.02); added paragraphs (b)(19.57), (b)(19.76), (b)(66.7), (b)(69.2), (b)(107.2), (b)(131.5), (b)(143.5), (b)(190.3), (b)(207.7), (b)(236.5), (b)(240.4), (b)(243.7), (b)(247.8), (b)(295.5), (b)(330.7), (b)(331.059), (b)(380.4), (b)(386.1), (b)(387.7), (b)(464.15), (b)(474.3), (b)(495.5), (b)(506.72), (b)(506.95), (b)(513.74), (b)(513.77), (b)(531.4), (b)(562.5), (b)(638.47), (b)(665.55), (b)(681.35), (b)(685.65), (b)(692.29), (b)(844.8), (b)(849.7), (b)(852.05), (b)(852.4), (b)(853.7), (b)(882.3), (b)(903.17), (b)(930.98), (b)(967.56), (b)(973.6), (b)(1021.1); added subsection (b.1); and added paragraph (c)(6.1). The second 2016 amendment, effective May 3, 2016, part of an Act to revise, modernize, and correct the Code, revised capitalization in subsection (a).

The 2017 amendments. The first 2017 amendment, effective April 17, 2017, added paragraphs (b)(13.531), (b)(68.13), (b)(97.4), (b)(217.4), (b)(244.2), (b)(331.053), (b)(355.6), (b)(355.8), (b)(430.7), (b)(472.51), (b)(506.97), (b)(520.2), (b)(528.1), (b)(658.7), (b)(661.03), (b)(661.05), (b)(661.96), (b)(663.36), (b)(663.6), (b)(769.37), (b)(835.5), (b)(848.2), (b)(1027.53), and (b)(1027.57); added " - See exceptions" at the end of paragraph (b)(13.55); deleted paragraph (b)(198.05), which read: "Clobazam;"; substituted the present provisions of paragraph (b)(673) for the former provisions, which read: "Reserved"; and added paragraph (c)(0.5). The second 2017 amendment, effective April 18, 2017, added " - See exceptions" at the end of paragraph (b)(635) and added paragraph (c)(14.25). The third 2017 amendment, effective July 1, 2017, made identical changes as the second 2017 amendment. The fourth 2017 amendment, effective May 9, 2017, part of an Act to revise, modernize, and correct the Code, revised capitalization in paragraphs (b)(.043) and (b)(133.05).

The 2018 amendment, effective May 3, 2018, added paragraphs (b)(.031), (b)(.041), (b)(.044), (b)(51.5), (b)(69.11), (b)(83.11), (b)(84.1), (b)(97.11), (b)(107.4), (b)(107.6), (b)(159.9), (b)(213.4), (b)(244.3), (b)(244.41), (b)(256.6), (b)(325.46), (b)(325.47), (b)(330.4), (b)(331.0701), (b)(331.7), (b)(346.7), (b)(355.7), (b)(415.04), (b)(432.91), (b)(474.1), (b)(512.8), (b)(513.78), (b)(534.3), (b)(617.2), (b)(632.1), (b)(640.11), (b)(640.25), (b)(644.61), (b)(661.2), (b)(680.3), (b)(731.01), (b)(742.1), (b)(838.6), (b)(849.8), (b)(851.2), (b)(852.06), (b)(853.9), (b)(931.61), (b)(1021.61), (b)(1021.71), (b)(1029.6), (b)(1037.9); added " - See exceptions" at the end of (b)(516.75); added paragraph (c)(12.91); and substituted "Lidocaine topical, 40 mg./gm. (4%)" for "Lidocaine topical ointment, 25 mg./gm." in paragraph (c)(13).

The 2019 amendment, effective May 7, 2019, added paragraphs (b)(30.4), (b)(62.03), (b)(69.101), (b)(76.3), (b)(76.8), (b)(97.7), (b)(98.6), (b)(116.3), (b)(124.1), (b)(154.3), (b)(154.4), (b)(236.8), (b)(317.1), (b)(325.8), (b)(331.051), (b)(331.052), (b)(331.068), (b)(331.9), (b)(334.9), (b)(334.92), (b)(386.9), (b)(406.93), (b)(406.94), (b)(408.95), (b)(414.5), (b)(415.02), (b)(463.01), (b)(474.01), (b)(506.85), (b)(511.55), (b)(512.69), (b)(528.4), (b)(529.94), (b)(531.8), (b)(531.9), (b)(617.35), (b)(622.8), (b)(625.2), (b)(663.355), (b)(692.295), (b)(692.519), (b)(742.05), (b)(805.3), (b)(832.05), (b)(836.7), (b)(842.05), (b)(851.15), (b)(852.5), (b)(881.01), (b)(892.5), (b)(930.91), (b)(930.975), (b)(930.976), (b)(931.51), (b)(943.3), (b)(966.5); added " - See exceptions" at the end of paragraphs (b)(333), (b)(867), and (b)(976); substituted "Reserved" for "Lacosamide" in paragraph (b)(509.7); inserted "dihydrochloride" in paragraph (b)(516.75); substituted "Reserved" for "Perampanel" in paragraph (b)(703.43); substituted "Reserved" for "Theobromine" in paragraph (b)(945.5); and added paragraphs (c)(9.33), (c)(12.95), (c)(25.05), and (c)(27.7).

The 2020 amendments. The first 2020 amendment, effective June 29, 2020, in subsection (b), added paragraphs (b)(17.05), (b)(17.4), (b)(22.7), (b)(106.3), (b)(107.1), (b)(107.45), (b)(107.7), (b)(132.7), (b)(151.55), (b)(154.45), (b)(217.7), (b)(240.65), (b)(331.054), (b)(332.1), (b)(332.86), (b)(334.91), (b)(381.25), (b)(383.2), (b)(396.3), (b)(408.1), (b)(415.01), (b)(424.6), (b)(506.6), (b)(512.691), (b)(513.4), (b)(531.45), (b)(531.75), (b)(706.7), (b)(740.7), (b)(746.5), (b)(768.5), (b)(772.5), (b)(832.9), (b)(843.15), (b)(845.2), (b)(853.8), (b)(858.4), (b)(930.901), (b)(931.79), (b)(974.2), (b)(981.5), (b)(985.5), (b)(1018.3), (b)(1019.7), (b)(1037.85), and (b)(1042.04), substituted "Reserved" for "Ethinamate" in paragraph (b)(361.5), and substituted "Reserved" for "Lorcaserin hydrochloride" in paragraph (b)(529.93). The second 2020 amendment effective July 1, 2020, inserted "or licensed distributor or wholesaler" in paragraph (c)(14.25). The third 2020 amendment effective July 29, 2020, part of an Act to revise, modernize, and correct the Code, redesignated former paragraph (b)(69.101) as present paragraph (b)(69.10); deleted former paragraph (b)(116.05) which read: "Reserved"; substituted "32 mcg." for "32 mcg" in paragraph (c)(6.1); substituted "1 mg. per 1 ml. or less or 10 mg. or less" for "1mg per 1ml or less or 10mg or less" in paragraph (c)(6.5); substituted "0.125 mg." for "0.125 mg" in paragraph (c)(9.33); substituted "0.05 mg." for "0.05 mg" in paragraph (c)(9.75); substituted "1 percent" for "1.0 percent" in paragraph (c)(10); substituted "5 mg." for "5 mg" in paragraph (c)(12.95); substituted "(4 percent)" for "(4%)" in paragraph (c)(13); substituted "55 mcg." for "55 mcg" in paragraph (c)(27.7); and substituted "(1.00 mg./5.00 ml.)" for "(1.00 mg/5.00 ml)" in paragraph (c)(31).

The 2021 amendments. The first 2021 amendment, effective May 4, 2021, in subsection (b), added paragraphs (b)(.033), (b)(43.5), (b)(54.5), (b)(65.7), (b)(68.14), (b)(69.105), (b)(78.2), (b)(81.5), (b)(91.75), (b)(132.9), (b)(148.5), (b)(195.6), (b)(213.45), (b)(332.88), (b)(334.85), (b)(388.4), (b)(396.4), (b)(406.935), (b)(409.1), (b)(472.3), (b)(495.3), (b)(510.5), (b)(529.05), (b)(531.43), (b)(531.73), (b)(535.5), (b)(540.4), (b)(638.43), (b)(643.5), (b)(661.55), (b)(663.71), (b)(665.53), (b)(680.1), (b)(692.545), (b)(769.1), (b)(832.95), (b)(832.97), (b)(842.5), (b)(843.13), (b)(843.17), (b)(849.3), (b)(851.5), (b)(853.85), (b)(853.87), (b)(855.73), (b)(881.07), (b)(930.905), (b)(931.33), (b)(931.83), (b)(967.58), (b)(988.5), (b)(1014.5), (b)(1029.8), and (b)(1030.7); substituted "Reserved" for "Brexanolone" in paragraph (b)(107.1); substituted "Reserved" for "Cenobamate" in paragraph (b)(154.45); substituted "Clopidogrel" for "Clopidogerel" in paragraph (b)(203); added " - See exceptions" at the end of paragraphs (b)(270.5), (b)(506.8), and (b)(663.2); substituted "Reserved" for "Lasmiditan" in paragraph (b)(512.691); and added paragraphs (c)(7.95), (c)(12.1), and (c)(16.85). The second 2021 amendment, effective May 10, 2021, part of an Act to revise, modernize, and correct the Code, substituted "(4 percent)" for "(4 precent)" in paragraph (c)(13); substituted "1 mg./ml. of naloxone" for "1 mg. l. of naloxone" in subparagraph (c)(14.25)(A); and substituted "0.4 mg./ml. of naloxone" for "0.4 mg. l. of naloxone" in subparagraphs (c)(14.25)(C) and (c)(14.25)(D).

Cross references.

- Schools authorized to stock supply of auto-injectable epinephrine, § 20-2-776.2.

Authority of director of Georgia Drugs and Narcotics Agency to compile and distribute pamphlet listing unlawful narcotics and dangerous drugs, § 26-4-29.

Code Commission notes.

- Pursuant to Code Section 28-9-5, in 1985, paragraph designated (509.1) in subsection (b) was correctly redesignated as (509.2).

Pursuant to Code Section 28-9-5, in 1986, in the first sentence of subsection (a) "U.S.C." was substituted for "USC".

Pursuant to Code Section 28-9-5, in 1988, a colon was substituted for a period at the end of the introductory language of subsection (c).

Pursuant to Code Section 28-9-5, in 1989, a period was substituted for the semicolon at the end of paragraph (c)(31).

Pursuant to Code Section 28-9-5, in 1990, a semicolon was substituted for a period at the end of paragraph (c)(11.6).

Pursuant to Code Section 28-9-5, in 1996, in subsection (a) and in paragraph (e)(8), "21 U.S.C. Section 301, et seq." was substituted for "21 U.S.C. 301 et seq."; a semicolon was substituted for a colon at the end of paragraphs (b)(402.8) and (b)(402.9); "mg." was substituted for "mg" in paragraphs (c)(7.1), (c)(9.5), and (c)(12.5).

Pursuant to Code Section 28-9-5, in 1997, "Reserved" was substituted for "Potassium perchlorate" in paragraph (b)(766).

Pursuant to Code Section 28-9-5, in 1998, paragraph (b)(66) was redesignated as paragraph (b)(68.5), paragraph (b)(67) was redesignated as paragraph (b)(66), paragraph (b)(67.3) was redesignated as paragraph (b)(67), new paragraph (b)(68.13) was redesignated as paragraph (b)(68.2), paragraph (b)(68.15) was redesignated as paragraph (b)(68.3), former paragraph (b)(68.2) was redesignated as present paragraph (b)(68.4), and former paragraph (b)(68.3) was redesignated as present paragraph (b)(68.6).

Pursuant to Code Section 28-9-5, in 2001, paragraph (b)(160.2) was redesignated as paragraph (b)(160.20).

Pursuant to Code Section 28-9-5, in 2007, paragraph (b)(616.05) was redesignated as paragraph (b)(615.9) and a misspelling of "solution" was corrected in paragraph (c)(12.7).

Pursuant to Code Section 28-9-5, in 2017, paragraph (b)(769.37), as added by Ga. L. 2017, HB 231, § 9/HB 231, was redesignated as paragraph (b)(769.33).

Pursuant to Code Section 28-9-5, in 2018, a semicolon was added at the end of paragraphs (b)(346.7), (b)(640.25), and (b)(731.01).

Editor's notes.

- Ga. L. 2012, p. 40, § 1/SB 370, not codified by the General Assembly, which provides for the annual update of the identity of controlled substances and dangerous drugs, is dedicated to the memory of Chase Corbitt Burnett and shall be known and may be cited as "Chase's Law."

Ga. L. 2017, p. 22, § 1/SB 121, not codified by the General Assembly, provides: "This Act shall be known and may be cited as the 'Jeffrey Dallas Gay, Jr., Act.' "

Ga. L. 2017, p. 319, § 1-1/HB 249, not codified by the General Assembly, provides: "This part shall be known and may be cited as the 'Jeffrey Dallas Gay, Jr., Act.'"

Law reviews.

- For survey article on criminal law and procedure, see 34 Mercer L. Rev. 89 (1982). For article on the 2017 amendment of this Code section, see 34 Ga. St. U. L. Rev. 143 (2017). For annual survey on healthcare law, see 70 Mercer L. Rev. 1053 (2019). For note on 2000 amendment of this Code section, see 17 Ga. St. U.L. Rev. 85 (2000).

JUDICIAL DECISIONS

Former Code 1933, § 79A-9915 plainly and specifically made the offenses charged, possession, sale, and delivery of an amphetamine, a felony and former Code 1933, § 79A-702 (see now O.C.G.A. § 16-13-71) did not require a different conclusion. Gee v. State, 225 Ga. 669, 171 S.E.2d 291 (1969).

In event of uncertainty, lesser of two penalties applies.

- When uncertainty develops regarding which penal clause applies, an accused is entitled to have the lesser of two penalties administered. Hartley v. State, 159 Ga. App. 157, 282 S.E.2d 684 (1981).

State's expert guess not competent evidence.

- In the prosecution of a juvenile for possession of Diphenhydramine, the state's expert, who had not weighed the drug and could not testify, based on accurate measurements, whether the amount of the drug was less than the amount excepted in O.C.G.A. § 16-13-71(c)(8), was not competent to testify, and the evidence adduced was insufficient for conviction. In re L.L., 207 Ga. App. 785, 429 S.E.2d 156 (1993).

Jury was authorized to conclude that the defendant intended to possess a dangerous drug in violation of the Dangerous Drug Act, O.C.G.A. § 16-13-70 et seq., even if the defendant was subjectively unaware of the precise chemical compound in the bottle and its regulated nature, because there was evidence supporting an inference that the defendant used a dangerous drug to sedate the defendant's sexual battery victim, and that conduct demonstrated the defendant's knowledge of the harmful effect of the compound; the term "dangerous drug" was defined to include alkyl nitrite, which was the compound the defendant possessed. Serna v. State, 308 Ga. App. 518, 707 S.E.2d 904 (2011).

Trial court did not err in convicting the defendant of possession of dangerous drugs in violation of the Dangerous Drug Act, O.C.G.A. § 16-13-70 et seq., because the variance between the allegations in the indictment and the proof at trial was not fatal since even though the indictment accused the defendant of possessing amyl nitrate, which was not included in the list of dangerous drugs, the bottle the defendant possessed contained alkyl nitrite, which was classified as a dangerous drug under the Act, O.C.G.A. § 16-13-71(b)(21.1); the defense was not compromised at trial, and the defendant was protected from a second prosecution for the same offense because the name of the indicted chemical and the proven chemical were similar, the indictment notified the defendant of the date of the offense, the type of offense, and the basis for the offense, and the defendant was convicted of the same offense listed in the indictment. Serna v. State, 308 Ga. App. 518, 707 S.E.2d 904 (2011).

Cited in Ellis v. State, 132 Ga. App. 684, 209 S.E.2d 106 (1974); Tischmak v. State, 133 Ga. App. 534, 211 S.E.2d 587 (1974); State v. Bonini, 236 Ga. 896, 225 S.E.2d 907 (1976); Little v. State, 157 Ga. App. 462, 278 S.E.2d 17 (1981); Ancrum v. State, 197 Ga. App. 819, 399 S.E.2d 574 (1990).

OPINIONS OF THE ATTORNEY GENERAL

Control of dangerous drugs is vested with the State Board of Pharmacy and the chief drug inspector (now director of Georgia Drugs and Narcotics Agency). 1975 Op. Att'y Gen. No. 75-23.

State Board of Pharmacy is empowered to regulate dispensing of drugs in hospitals.

- Dispensing of drugs in hospitals by machine or otherwise is a matter which the legislature has left to the State Board of Pharmacy to regulate through its rule-making power. 1969 Op. Att'y Gen. No. 69-85.